New data has just been released on the next generation of weight management and metabolic optimization peptides. This is generating weight loss numbers that were unheard of 5 years ago. In a new clinical study published in the New England Journal of Medicine, Cagrilintide was coadministered with Semaglutide in adults with obesity.

Groundbreaking Study on Cagrilintide and Semaglutide Combination

This study was a 68-week multicenter study enrolling adults without diabetes for weight loss. These patients had a body mass index of 30 or greater. The body mass index (BMI) is calculated by the weight in kilograms divided by the square of the height in meters. A total of 3417 participants with 2108 assigned to receive the combination of both semaglutide at 2.4 mg and cagrilintide at 2.4 mg, or semaglutide alone or cagrilintide alone. Although all participants using the combination or either drug alone had weight loss, the combination achieved superior results up to 30% loss of body weight. Side effects with the combination was 79.6% with the combination and 39.9% in the placebo group. These were mild and transient including nausea, vomiting, diarrhea and constipation.

How Cagrilintide Works to Enhance Satiety and Weight Loss

Cargrilintide is a long-acting amylin analogue, a synthetic cousin of the hormone amylin which is naturally secreted along with insulin from the pancreas. Amylin works in blood sugar regulation and satiety. It signals through the brain to “stop eating” and aids in blood sugar regulation.

Weight Loss Outcomes Compared: CagriSema vs Semaglutide Alone

In the study above, when semaglutide was paired with cargrilintide, all participants lost an average of 20.4% of their total body weight over the 68-week period of the study. Semaglutide alone produced a 15% reduction and cagrilintide alone reduced weight by 11-12%. This is a significant reduction when combined and the researchers theorized that each works at the receptor level.

Mechanisms of Action: GLP-1 and Amylin Pathways

GLP-1 agonists increase insulin secretion and suppress glucagon. They also slow gastric emptying making the patient feel full for a longer period after eating. Cagrilintide acts on the amylin pathway, delivering satiety signals directly to the brain. It also retards gastric emptying rates. The side effects are similar to the GLP-1 medications, but it has been reported that cagrilintide can cause an emotional flat affect. The dosage is .25mg 2-3 times a week with the GLP-1 and titrate up.

Retatrutide and Future Triple Agonist Therapies

When added to Retatrutide, the triple agonist, this combination should reduce weight by 30-40%. This combination is currently under investigation. Initially, the Glucagon like peptide -1 (GLP-1) was introduced then the Dependent Insulinotropic Polypeptide Dual Agonist (GIP) and finally the triple action of Retatrutide which adds the glucagon receptor agonists.

Study

Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity
Published June 22, 2025, DOI:10.1056/NEjMoa2502081 PMID 40544433
Background: Semaglutide at a dose of 2.4mg has established weight loss and cardiovascular benefits and Cagrilintide at a dose of 2.4 mg has shown promising results in early phase trials, the efficacy of the combination known as CagriSema on weight loss in persons with either overweight or obesity is unknown.
Conclusion: cagrilintide-semaglutide provided significant and clinically relevant body weight reductions in adults.

Study

Cagrilintide-Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes
N Engl J Med 2025 Jun 22 PMID 40544432
Background: Cagrilintide and Semaglutide have been each shown to induce weight loss as monotherapies. Data are needed on the coadministration of cagrilintide and semaglutide for weight management in adults with type 2 diabetes.
Conclusions: Once weekly cagrilintide semaglutide resulted in a significantly lower body weight in adults with type 2 diabetes and obesity.

The Impact of Weight Loss on Muscle Mass and Skin Laxity

The amount of weight loss that can be provided by this combination of peptides is beyond significant. Ultimately, there will be a huge reduction in diabetes, cardiovascular disease, hypertension, strokes and other major diseases. However, there will be other consequences to this amount of weight reduction. With weight reduction, many patients lose an appreciable amount of muscle mass unless weight training is part of the overall protocol. Large weight reduction, with loss of muscle equates into loose skin, obvious stretch marks, creepy skin, and visible cellulite. Jelly Roll, the country rocker, recently formally announced his major weight loss and plans for needed plastic surgery to remove loose skin. With millions of Americans on GLP-1 meds and losing weight, not every patient can afford to obtain plastic surgery.

What Are the Alternative Options for Loose Skin, Fat Pockets and Striae?

Platelet Rich Plasma

Platelet Rich Plasma is an autologous blood concentrate that is rich in cytokines, growth factors and bioactive proteins. PRP has been used in all fields of medicine and is well established for its regenerative capabilities. In striae distensae, which are dermal scars associated with atrophy of the epidermis, PRP is extremely effective. Biopsies taken after the use of PRP on stretch marks show collagen and elastin fibers were increased.

Study

Platelet Rich Plasma Versus Tretinoin in Treatment of Striae Distensae: A Comparative Study
Dermatol Surg 2018 May;44(5):697-704 PMID 29701622
Objective: To evaluate the effect and safety of intralesional injection of platelet rich plasma versus topical tretinoin in the treatment of SD.
Conclusion: PRP injection and topical tretinoin are safe for the treatment of SD, but PRP is more effective, and it gives better therapeutic response than tretinoin.

PhysioPRO Shockwave Therapy System

Extracorporeal shockwave therapy (ESWT) is a noninvasive treatment option for improving skin laxity and body contouring. It utilizes acoustic waves to stimulate collagen production and enhance skin elasticity. When employed in a targeted area, high energy waves promote blood circulation and cellular repair. The collagen and increased vascularity can tighten skin over time. ESWT is effective for sagging skin in areas such as the abdomen, thighs and triceps. It can also assist in reducing the appearance of cellulite. Results vary by the individual and take several weeks to become noticeable as collagen builds. Multiple treatments are needed often spaced weeks apart and side effects to the therapy with the shockwave are minimal.

Study

Cellulite and Focused Extracorporeal Shockwave Therapy for Non-invasive Body Contouring: A Random Trial
Dermatol Ther 2013 Dec 3;(2):143-155 PMID 24297647
Conclusion: ESWT and gluteal strength training improved cellulite and contoured the buttock area by 24% over control groups.

Radiofrequency

Radiofrequency skin tightening is another nonsurgical treatment to treat sagging skin. Radio frequency devices use safe levels of low frequency electromagnetic waves to generate heat. The heat penetrates deep into the layers of the skin. There, it stimulates new skin regeneration by stimulating the production of collagen and elastin. Collagen and elastin provide the skin cells with more strength and flexibility. This process results in the skin regaining its prior shape and feel. Radiofrequency improves the skin tone, texture and firmness and reduces the skin’s wrinkles, fine lines and sagginess. RF is utilized in body contouring especially in the face, neck, arms and hands.

Study

Noninvasive Radio Frequency for Skin Tightening and Body Contouring
Cutan Med Surg 2013 Mar;32(1):9-17 PMID 24049924
RF thermal stimulation is believed to result in a microinflammatory process that promotes new collagen. By manipulating skin cooling, RF can be used for heating and reduction of fat. Currently, the most common use of RF based devices are to noninvasively manage and treat skin tightening of lax skin (including sagging jowls, abdomen, thighs and arms) as well as wrinkle reduction, cellulite improvement and body contouring.

Low Level Laser Therapy

The use of low-level laser therapy (LLLT) is called photobiomodulation. Photobiomodulation therapy is defined as a form of light therapy that utilizes nonionizing light sources in the visible (400-700) electromagnetic spectrum. Gaining popularity in clinical practice for body contouring, the treatment protocols vary depending on the adipose makeup of the patient.

Study

Photobiomodulation Therapy for Improvement of Body Contour: A Retrospective Study on Middle Eastern Participants
Iran J Public Health 2024 Aug;53(8):1858-1863 PMID 39415875
Background: The rising demand for body contouring and concerns about side effects of invasive surgical procedures have led to advances in providing new noninvasive alternative methods for weight reduction. The current retrospective study investigated the safety and efficacy of photobiomodulation technology in reducing local obesity in Middle Eastern participants.
Conclusion: This study demonstrated the effectiveness and safety of photobiomodulation in reduction of circumferential size in abdomen, buttock, thigh and arm areas in Middle Eastern participants with high patient satisfaction an acceptable safety profile.

Juventix Regenerative Solutions for Post-Weight Loss Skin Tightening

These are a few of the options available for the treatment of loose skin and pockets of fat deposits that occur after a significant weight reduction. Surgery is not the only option. Juventix Regenerative Medical is an industry leader in the regenerative medical field. Our Platelet Rich Plasma Kits are FDA cleared and designed for safety, sterility and effectiveness and are currently being utilized by regenerative professionals around the world. However, Juventix Regenerative Medical has so much more to offer. In the treatment of body contouring, the PhysioPRO is a clinical grade extracorporeal shockwave device that induces intracellular and extracellular reactions to regenerate and tighten tissues.

Juventix Regenerative Medical offers the Apollo Duet. This device incorporates three aesthetic applications, electroporation and ionophoresis to penetrate the skin without the use of a needle and achieve penetration of serums into the deeper layers of the skin. The second modality is 4th generation radio frequency to stimulate collagen and elastin production to tighten loose skin areas.

Juventix Regenerative Medical also offers the Gemstone Laser. This device generates 532 wavelength light to stimulate cellular lipolysis. This removes stubborn fat deposits by working at the cellular level to open the fat cells and their contents are dissipated naturally by the body. This results in body tightening and sculpting. All without needles or pain. Improvements can be visualized in as little as two treatments.

Dramatic weight loss is now commonplace and so is loose, lax skin with pockets of fat.

Juventix Regenerative Medical has the solutions.

RESTORE, REVIVE, REGENERATE – JUVENTIX REGENERATIVE MEDICAL

Regenerative Regards,

Dr. Robert McGrath

The post Next-Gen Weight Loss Medications & PhysioPRO Shockwave Therapy for Loose Skin appeared first on Juventix.

Polydeoxyribonucleotide (PDRN) is a DNA derived biopolymer with regenerative, anti-inflammatory and tissue repairing properties. Extracted primarily from the sperm of salmon species, PDRN is fast becoming the new darling of aesthetic and regenerative medicine. This molecule has been widely used in South Korea and has received accolades in the aesthetic marketplace. However, in The United States, PDRN is not well known. This article will provide an overview of the biologic function, aesthetic benefits and safety concerns as well as evidence supporting the clinical efficacy of PDRN.

Polydeoxyribonucleotide is a low molecular weight DNA fragment composed of deoxyribonucleotides derived from fish sperm. Commonly used species are rainbow trout (Oncorhynchus mykiss) or chum salmon (Oncorhynchus keta). It is classified as a biologic and considered a DNA based compound. PDRN can promote tissue repair, regeneration and angiogenesis.

PDRN is a mixture of DNA fragments that function together to stimulate the A2A adenosine receptor, modulating inflammation, promoting cell proliferation and supporting tissue repair pathways of DNA synthesis.

Mechanism of Action

Polydeoxyribonucleotide is not present in the human body. It mimics endogenous nucleotides and participates in tissue repair through several biologic pathways.

Activation of Adenosine A2A Receptors

This pathway results in anti-inflammatory signaling reducing inflammatory cytokines such as TNF-alpha and IL-6. A2A receptors are a type of adenosine receptor that plays a significant role in the regulation of immune function, inflammation, and neurological function.

DNA Salvage Pathway

PDRN provides needed nucleotides in the formation of DNA synthesis. This is critical in rapidly regenerative tissue. It augments the action of the fibroblasts and keratinocytes.

Stimulation of Fibroblast Growth and Collagen Production

Enhances the integrity of the extracellular matrix and improved dermal elasticity.

Angiogenesis

PDRN supports the formation of new vasculature in regenerating tissues.

Sources and Extraction

PDRN is harvested from the sperm of fish especially salmon due to their DNA similarity to humans and extremely low immunogenicity. The DNA is purified through a process of enzymatic hydrolysis and heat processing. This ensures the removal of specific proteins and immunogenic components. The salmon sperm DNA is the preferred choice due to its safety, scalability and high nucleotide yield. Salmon sperm and the processing makes it useful for medical and cosmetic applications.

Despite PDRN being derived from salmon sperm, it does not contain proteins responsible for fish allergies. The common culprit responsible for fish allergies is parvalbumin. Purification removes immunogenic proteins making it generally safe for individuals with fish allergies. However, in highly atopic or allergic patients, supervision is always advised.

Aesthetic Medicine and PDRN

Skin Rejuvenation
Topicals and injectable applications improve dermal thickness.
Topicals and injectable applications reduce fine lines and wrinkles.
Overall, applications brighten skin and improve texture.
Studies have proven enhanced collagen production and increased skin hydration.

PDRN can and is often combined with hyaluronic acid, growth factors, exosomes, platelet rich plasma and peptides to augment tissue regeneration. This is particularly noted in regenerative facial treatments and injectables.

Advantages in Aesthetic Use

• Non-immunogenic and safe for repeated usage.
• Anti-inflammatory and beneficial in acne and rosacea prone skin.
• Tissue regeneration promoting the synthesis of collagen and elastin.
• Post procedure recovery is enhanced, reducing downtime and augmenting results.
• Clinically proven visible improvement in wrinkles and skin elasticity especially in the periorbital area after a series of treatments.

Side Effects

Significant side effects are rare.
Mild transient erythema or swelling at the injection site.
Allergic reactions are extremely rare due to the high purification process and standards.

In wound healing, deoxyribonucleotide has been studied and proven to promote wound healing by promoting angiogenesis and epithelial regeneration. It is especially useful in post laser or micro needling recovery. PDRN reduces scar formation when utilized post treatment.

PDRN is clinically proven, safe, and effective agent for tissue regeneration and aesthetic applications. It is firmly solidified as a staple in Korean skincare and global aesthetic medicine due to the multifaceted roles in wound healing, anti-inflammation and dermal rejuvenation.

Clinical Studies on PDRN

PDRN prevents SIRT1 Degradation by Attenuating Autophagy During Skin Aging
PLoS One 2025 May 9;20(5):e0321005 PMID 40343916

Skin aging is a complex process influenced by many factors, such as ultraviolet radiation from the sun and oxidative damage. In this study, we utilized UVB induced photoaging or H2O2 induced oxidative stress models to explore the effects of PDRN on anti-aging. The findings revealed that keratinocytes exhibited significantly reduced cell proliferation and increased cell apoptosis when exposed to UVB or H2O2. Findings indicated that PDRN protects cells from UVB and H2O2 damage. We hypothesized that PDRN promotes cell proliferation by modulating the expression of key genes.

Silent information regulator 1 (SIRT1) plays an essential role in antioxidant, anti-apoptotic and senescence process. In this study, PDRN significantly upregulated SIRT1 expression at protein levels and attenuates stress granules in the cytoplasm, particularly under UVB and H2O2 stimulation, implying PDRN decreases skin aging by promoting the expression of SIRT1.

Human skin aging is characterized by thinning, fragility and hyperpigmentation. In order to verify the anti-aging effect of PDRN on the human skin, we administered UVB radiation to mice to stimulate the characteristics of human skin aging. H&E results showed that UVB radiation induced skin atrophy, thinning of the epidermal layer and cellular reduction in the skin of mice but the aging skin could be restored to the same level as that of controls after treatment with PDRN. This implies that PDRN can greatly alleviate the skin photodegradation induced by UVB.

Conclusion: This study demonstrates that PDRN effectively inhibits the aging of keratinocytes by upregulating Silent Information Regulator 1 (SIRT1) expression and reducing nuclear autophagy when exposed to UVB or H2O2 induced senescence. These findings reveal the cellular anti-aging properties of PDRN and provide insights into the mechanism underlying its potential as a natural ingredient in skincare products.

Polydeoxyribonucleotide: A Promising Biological Platform to Accelerate Impaired Skin Wound Healing
Pharmaceuticals 2021 Oct 29;14(11):1103 PMID 34832885

This study investigated the use of PDRN in wound healing.

Conclusion: Regarding safety, acute and chronic toxicity studies in mice were undertaken to evaluate the repeated systemic administration of PDRN which showed no toxic effect in the brain, liver, lungs, skeletal muscle and heart and did not cause mortality. In this clinical study on the effects of PDRN on the healing of chronic diabetic wounds, safety and tolerability were excellent.

The combination with bioactive materials including hydrogels, scaffolds, nanofibers and films enhance the pharmacological activity of PDRN and offer important advantages in wound healing and tissue engineering.

The Effectiveness of Polynucleotides in Aesthetic Medicine: A Systematic Review
J Cosmet Dermatol 2025 Feb;24(2):e16721 PMID 39645667

Background: Polynucleotides, popular in bio revitalization, show promise in the current sphere of aesthetic medicine due to their regenerative properties, previously used in wound healing. The aim of this review was to synthesize the existing literature, focusing on the effectiveness of PDRN in aesthetic medicine, which is concentrated on skin rejuvenation by providing patients with multiple benefits and the least side effects.

Conclusion: Polynucleotide injections have shown promising outcomes in reducing wrinkles, improving skin texture and enhancing elasticity with statistically significant results in several studies. While side effects are generally mild and transient, patient satisfaction is moderate to high suggesting PDRN treatment is well tolerated and effective cosmetic intervention.

Juventix Regenerative Medical: Advanced PDRN Delivery

Juventix Regenerative Medical is an industry leader in the regenerative medical field. Juventix is now proud to offer the LuxsQueen core serum line of products. These encompass anti-aging, acne and skin brightening lines of products. Polydeoxyribonucleotide is included in these serums.

Juventix Regenerative Medical has devices that will deliver these serums into the skin without the use of needles. The Apollo Duet device utilizing a combination of electroporation and iontophoresis to drive products to lower skin surfaces. Privive serum which can be combined with exosomes, platelet rich plasma and other biologics to chemically absorb into the lower skin layers and to speed recovery post procedure.

Juventix Regenerative Medical has answered the need for pain free, needle free delivery options for use by all members of the med spa community. When combined with LuxsQueen serums, exosomes, peptides or platelet rich plasma, excellent results are obtained leading to greater outcomes with enhanced patient satisfaction.

RESTORE, REVIVE, REGENERATE – JUVENTIX REGENERATIVE MEDICAL

Regenerative Regards,
Dr. Robert McGrath

The post Polydeoxyribonucleotide (PDRN): The New Face in Aesthetics appeared first on Juventix.

Pre-Aging Skin Treatment refers to the premature onset of visible and functional signs of aging in younger individuals, typically between 25-35 years of age. This condition is influenced by genetic, environmental and lifestyle factors that accelerate skin aging before chronological markers would suggest.

What is Pre-Aging?

Skin aging is traditionally associated with chronological progression however a growing number of individuals in their 20’s and 30’s are presenting with dermal deterioration. Dermatologists and aestheticians have termed this condition, pre-aging. This is characterized by loss of elasticity, dull complexion, fine lines and uneven texture.

Causes of Pre-Aging

Intrinsic Factors

Genetic predisposition with reduced collagen and elastin production
Hormonal imbalances with elevation of stress related cortisol levels

Extrinsic Factors

Ultraviolet exposure and photoaging of the skin.
Pollution induced oxidative stress.
Skin care neglect or overuse of harsh chemical treatments.
Blue light chronic exposure.
Lifestyle causes such as poor nutrition, lack of exercise, smoking, use of drugs etc.

Physical Changes Seen in Pre-Aging

1. Fine lines, wrinkles and expression wrinkles. These are caused in part due to collagen and elastin degradation and lack of production. This causes less dermal support developing crows’ feet, frown line, and forehead creases.
2. Loss of radiance and glow caused by decreased microcirculation and lack of retained moisture. This makes the skin appear dull, less vibrant and fatigued.
3. Dull and uneven skin tone caused by accumulation of dead skin cells. This reduced cell turnover leads to a poor dull complexion. The poor cell turnover rate can cause early hyperpigmentation areas and sunspots due to UV exposure and insufficient photoprotection.
4. Enlarged pores and early skin texture changes because of sebaceous gland activity and environmental damage. These are found commonly on the nose and cheeks. Skin appears rough due to barrier impairment and decrease desquamation.
5. Dryness and dehydration as a result of a compromised skin barrier. This results in tightness, flakiness and increased sensitivity. This is often complicated with harsh skincare products.
6. Vascular changes and redness with mild telangiectasias and persistent erythema on the nose and cheek areas due to chronic UV light exposure.
7. Periorbital changes are common in pre-aging with dark circles, puffiness and thinning skin in the orbital area.
8. Glycation is common with loss of suppleness and an overall yellowish tone. This is a result of advanced glycation especially in individuals with high sugar in their diets or oxidative stress with high cortisol levels.
9. Changes in the skin biome and barrier integrity leads to a rosacea like appearance and commonly treated with acne medications which makes the condition worse.

The above are some of the physical signs of pre-aging but not all. They are early biomarkers for significant future aging of the skin and should be delt with promptly to prevent further damage.

Pre-Aging Treatments and Their Mechanisms at the Cellular Level

The goal of treatment of pre-aging is to preserve youthful skin and function, restore homeostasis and prevent and reverse oxidative, inflammatory and structural damage before it becomes irreversible. These are some of the key treatment categories and their cellular mechanisms of action.

Sunscreens and Physical Photo protectants

(eg. Zinc oxide, titanium dioxide, tinosorb)

These agents reduce formation of reactive oxygen species and inflammatory mediators in keratinocytes and fibroblasts. They inhibit metalloproteinase expression which leads to the breakdown of collagen. They also block UVA/UVB radiation preventing the DNA damage caused by this spectrum of light.

Barrier Repair and Moisturizing Agents

(eg. Ceramides, hyaluronic acid, squalene, panthenol)

These agents help rebuild the stratum corneum lipid matrix preventing water loss. Hyaluronic acid binds up to 1000x its weight in water, expanding the extracellular matrix volume and improving hydration. These agents support the skin junction integrity while enhancing keratinocyte function and communication.

Antioxidants

(eg. Vitamin C, Vitamin E, Niacinamide, Resveratrol, Ferulic Acid)

These agents neutralize free radicals such as ROS generated by UV pollution and inflammation which causes DNA damage and lipid peroxidation. Vitamin C stimulates collagen synthesis as a cofactor for prolyl and lysyl hydroxylase in collagen formation. They enhance barrier function by reducing oxidative stress and damage to keratinocytes and fibroblasts. Finally, they downregulate inflammatory cytokines such as IL-6 and TNF-alpha which both cause matrix breakdown.

Retinoids and Retinol Alternatives

(eg. Retinol, tretinoin and bakuchiol)

These compounds bind and upregulate collagen and elastin gene expression in dermal fibroblasts. They normalize the function of the keratinocytes reducing hyper keratinization. They bind to nuclear receptors in skin cells modulating gene transcription. Bakuchiol mimics retinoid activity but also possesses anti-inflammatory and antioxidant effects and does not activate retinoid receptors. This decreases skin dryness and irritation as seen with most retinoids.

Peptides and Growth Factor Mimetics

(eg. Acetyl Dipeptide 31 Amide, Palmitoyl Tripeptide 1, Matrixyl, GHK-Cu)

These are cellular peptides which stimulate fibroblasts to increase collagen synthesis. Peptides reduce matrix metalloproteinases that degrade collagen under oxidative or UV stress. They maintain epidermal integrity by keratinocyte proliferation and promote wound healing. Acetyl Dipeptide 31 Amide modulates neurogenic inflammation reducing cortisol induced cell damage and upregulates stress protective proteins.

Micro needling and Low-Level Laser Light Therapy (LLLT)

Micro needling induces a controlled micro-injury that stimulates the wound healing cascade. In turn, activation of fibroblasts migration and TNF-beta signaling occurs increasing collagen and elastin deposition. Micro needling enhances topical product penetration through the microchannels made in the stratum corneum and below.

LLLT using photo biomodulation by red or near infrared light enhances mitochondrial ATP production in the dermal cells. This increases cytochrome c oxidase activity supporting repair and reducing oxidative stress.

The Power of Acetyl Dipeptide 31 Amide and Bakuchiol

The most recent and studied combination for pre-aging is Acetyl Dipeptide 31 Amide and Bakuchiol. They have synergistic effects in the treatment of this condition.

Acetyl Dipeptide 31 Amide

1. Acts on neuromodulator pathways reducing inflammation and cortisol related skin damage.
2. Reduces sensory neuron stimulation minimizing redness and sensitivity.
3. Increases epidermal stem cell expression.

Bakuchiol

1. Stimulates collagen types 1, 3, and 4 expression without binding retinoid receptors.
2. Reduces early pigmentation changes by improving melanin dispersion.
3. Reduces lipid peroxidation and inflammation in fibroblasts.

Both ingredients, reduce oxidative and inflammatory damage while promoting fibroblastic activity and overall skin homeostasis. These compounds delay the transition from pre-aging to aging skin while preserving youthful appearance and skin structure.

Cellular Benefits of Treating Pre-Aging Early

The treatment of pre-aging works at the cellular level to perform the following:

1. Protect against oxidative stress.
2. Enhance collagen synthesis and matrix repair.
3. Improve barrier function and increase hydration.
4. Reduce inflammation and hormonal signaling.
5. Promote cell turnover and epidermal regeneration.

The Importance of Early Detection and Treatment

The pre-aging population represents both a challenge and an opportunity to impact the course of skin aging. Early interventions can delay the more advanced stages of this disease. Studies show that more free radicals are generated in younger skin after exposure to agents such as UVA than in older skin. However, younger skin is more responsive to treatments and prevention. Therefore, early detection and therapy is mandatory in this group of individuals to reduce the current epidemic of pre-aging skin.

Studies

Counteracting Skin Aging in Vitro by Phytochemicals
J Cell Mol Med 2025 Apr;29(7): e70530 PMID 40181572

Combined Multilevel Anti-Aging Strategies and Practical Applications of Dermocosmetics in Aesthetic Procedures
J Eur Acad Dermatol 2024 Jul;38 Supp 4:23-35 PMID 38881448

A Scientific Approach to Defining, Evaluating, and Treating Pre-Aging with a Cosmetic Regimen Containing a Novel Cosmetic Peptide, Acetyl Dipeptide-31 Amide
J Drugs Dermatol 2025 May 1;24(5):51181s-14 PMID 40327583

Juventix Solutions for Pre-Aging Skin Treatment

Juventix Regenerative Medical offers the most current treatments, devices and biologics to treat and combat aging of the skin. Juventix Regenerative Medical has topicals such as peptides, exosomes and Privive Serum, which is an advanced skin permeation system.

Juventix Regenerative Medical provides devices such as the Radiance RF and NanoPen for micro needling. The DermaMend Laser for the specific use of therapeutic wavelengths of light is available for various skin applications.

Juventix Regenerative Medical now offers the Apollo Duet which applies electroporation and iontophoresis to drive various serums and platelet rich plasma into the deep tissues without the piercing of the skin.

Juventix Regenerative Medical is a leader in regenerative medical products. From Platelet Rich Plasma to the Apollo Duet, with customer support and professional consultant assistance not seen with other competitors, Juventix is the leader in the regenerative medical field.

RESTORE, REVIVE, REGENERATE – JUVENTIX REGENERATIVE MEDICAL

Dr. Robert McGrath

The post Pre-Aging Skin: Causes, Signs, and Treatments appeared first on Juventix.

Softball has become a popular sport for young and old alike. There are leagues for collage, professionals, women, men, golden age participants and Olympic athletes. In the United States alone there are 245,000 teams playing all levels of softball.

It is interesting to note how the game was invented. The earliest known softball game was played in Chicago on Thanksgiving Day in 1887. It took place when a gathering of men waited to hear the results of the Harvard Yale football game. When the score was announced and all bets were paid, a Yale alumnus threw a boxing glove at a Harvard supporter. The Harvard grad grabbed a stick and hit the rolled-up glove and another man yelled, “Play Ball”. The game of softball began, and the boxing glove was tightened into a ball and a broom handle served as a bat. Since the ball was soft, softball was invented.

Softball Participation and Injury Trends in the United States

Since the invention, softball has become one of the most popular sports in the US. Some estimates are that 40 million Americans will play at least one softball game a year. With young and old participating in this sport, injuries are a common occurrence.

Senior softball is thriving in the United States with more than 1.5 million active players aged 50 and above participating in leagues nationwide. Senior Softball USA reports teams in all 50 states and parts of Canada, with divisions for players in their 50s, 60s, 70s, and even 80 and above. The surge in participation highlights the importance of injury prevention and strategies tailored to older athletes.

The Silver Senior Softball League of South Jersey was contacted and asked about the most common injuries incurred during participation. They noted five common injuries.

• Hamstring injuries
• Sprains and strains
• Tendinitis
• Shoulder and rotator cuff injuries
• Fractures

Risk Factors for Hamstring Injury

• Age- Senior players are at high risk due to reduced muscle elasticity and strength.
• Previous Injury- Hamstring injuries have a high rate of reoccurrence.
• Fatigue- sore overstressed muscles are prone to injury.
• Poor biomechanics- improper running technique or posture
• Obesity-Hamstrings can be overloaded with excess weight bearing.

Anatomy of the Hamstring

The hamstring muscle group consists of three muscles located at the posterior thigh. These are the semitendinosus, semimembranosus and the biceps femoris. These muscles originate from the ischial tuberosity and insert below the knee joint. Their primary function includes hip extension and knee flexion. The biceps femoris has a long and short head, with the long head being biarticular. This muscle is the commonly injured in hamstring injuries due to the complex role during sprinting.

Prevention Strategies

• Proper Warm Up with dynamic stretches and progressive movement drills.
• Strength training with focus on hamstrings, core and glutes
• Flexibility to maintain normal ranges of motion.
• Overall conditioning and agility drill specific to the activity
• Biomechanics analysis to evaluate and identify movement flaws.

Standard Treatment Options

Standard treatment of hamstring injuries includes the RICE protocol (rest, ice, compression and elevation), non-steroidal anti-inflammatory agents and rehabilitation. Physical therapy with neuromuscular training and stretching are an integral part of the recovery protocol.

In complete tears, surgical repair may be needed but surgery may prolong recovery times and lead to common surgical complications.

Recovery Timeline by Grade

• Grade 1- mild strain- typically 1-2 weeks, minimal pain and no significant lost strength.
• Grade 2- partial tear- 4-8 weeks, noticeable pain, swelling and weakness.
• Grade 3- complete tear- 3-6 months or more, severe pain, bruising and loss of function.

Diagnosis is typically clinical with confirmation by ultrasound or MRI.

Re-injury is common with approximately 30% recurrence rates in highly trained athletes in the same season. Older individual’s reoccurrence rates are higher.

In professional soccer, in the most elite leagues, each hamstring injury cost the club approximately $30-$50 thousand dollars in lost wages and associated costs. In the NFL, hamstring injuries are among the top causes of missed playing time. In high caliber players, each lost game can contribute to millions of dollars in lost player availability annually.

Platelet Rich Plasma (PRP) for Hamstring Injury Treatment

Platelet Rich Plasma is an autologous blood derived concentrate, rich in growth factors, cytokines and bioactive proteins. In thousands of published peer reviewed and double blind studies, platelet rich plasma has been proven to regenerate damaged tissues.

Platelet Rich Plasma contains growth factors that stimulate muscle repair and rejuvenation in injuries such as hamstring tears and ligamentous injuries.

• Insulin like Growth Factor – stimulates muscle cell proliferation, differentiation and repair. It has a variant called IGF-1Ea and IGF-1Ec called Mechano Growth Factor which localizes to muscle and is highly anabolic after injury.
• Fibroblast Growth Factor – supports cell proliferation and angiogenesis during muscle healing.
• Hepatocyte Growth Factor – activates quiescent satellite cells which are often released after acute injury.
• Vascular Endothelial Growth Factor – promotes blood vessel growth supporting oxygen and nutrient delivery to regenerating muscle.
• Transforming Growth Factor Beta – stimulates collagen synthesis and promotes extracellular matrix remodeling.
• Platelet Derived Growth Factor – stimulates fibroblast proliferation and collagen production in tendon and ligament repair.
• Fibroblast Growth Factor – involved in tendon repair promoting fibroblast proliferation and new collagen formation.

There have been at least 300 growth factors identified and carried on the granules of the platelets. These are released into areas of tissue damage and activate the overall bodies repair cascade. Studies have proven a 26% reduction in return to play time for hamstring injures when platelet rich plasma is used in the treatment.

Clinical Studies Supporting PRP

Update on the Use of Platelet Rich Plasma Injections in the Management of Musculoskeletal Injuries: A Systematic Review of Studies From 2014 to 2021
Orthop J Sports Med 2022 Dec 9;10(12): 23259671221140888 PMID 36532150
Purpose: To determine if there are any recent studies that show any clear benefits regarding the use of PRP in the management of soft tissue injuries
Conclusion: Six studies examined PRP in acute soft tissue injuries with two of these reporting significant improvements in recovery time for hamstring injuries.

Hamstring Injuries: A Current Concepts Review: Evaluation, Nonoperative Treatment, and Surgical Decision Making
Am J Sports Med 2024 Mar;52(3):832-844 PMID 37092718
Conclusion: Many hamstring injuries can be successfully managed with nonoperative measures such as activity modification and physical therapy and adjuncts such as platelet rich plasma injections.

Platelet Rich Plasma Injection for the Treatment of Hamstring Injuries: A Systematic Review and Meta-analysis with Best-Worst Case Analysis
Am J Sports Med 2021 Feb;49(2):529-537 PMID 32427520
Conclusion: There has been statistically nonsignificant evidence to suggest that PRP injection and physical therapy reduced return to play or reinjury rates compared to no treatment or physical therapy alone for hamstring injuries in a short term follow up.

Authors note: In review of this study, there was improvement in all areas reviewed. Although this author concluded it was not significant statistically.

Hamstring Injury Treatments and Management in Athletes: A Systematic Review of the Current Literature
JBJS Rev 2023 Nov 20;11(11). Doi: 10.2106/JBJS.RVW.23.00161 PMID 37983561
Conclusion: Treatments for hamstring injuries exhibit varied efficacy. Although rest, ice, compression and elevation remain essential for acute management, rehabilitation focusing on muscle strengthening and flexibility is critical. The potential benefits of platelet rich plasma injections, especially in chronic cases, requires more research.

Authors note: Research and studies all show benefit of platelet rich plasma for hamstring injuries. However, in some studies the benefit was not deemed to be significant. There were no noted side effects from the platelet rich plasma and in most cases, the amount of PRP, the number of injections, the activation method and the mode of image guidance was not mentioned. With the amount of growth factors, cytokines and bioactive protein that are contained in platelet rich plasma, no allergic manifestations and a favorable side effect profile, consideration should be given for platelet rich plasma to be a cornerstone in the treatment protocol for these injuries.

Juventix Regenerative Solutions for PRP and Soft Tissue Recovery

Juventix Regenerative Medical is an industry leader in the regenerative medical field. Our Platelet Rich Plasma Kits are designed for safety, sterility and effectiveness. Our kits are FDA cleared and scientifically manufactured to provide a platelet concentrate, devoid of red blood cells with a minimum number of leukocytes that are critical for the regenerative process.

Juventix Regenerative Medical offers a patented LED Activator to activate the platelets and begin the regenerative process. The activation is a critical step in the release of growth factors, cytokines and bioactive proteins from the granules that are contained on the platelets and is accomplished with LED light. This negates the use of chemical additives such as Calcium Chloride, Thrombin or Collagen. This mode of activation by LED light provides sustained growth factor release versus older methods of activation while adhering to the minimal manipulation standards of the FDA.

Juventix Regenerative Medical is proud to be a distributor of the PhysioPRO Shockwave System. This clinical grade radial shock wave device induces intracellular and extracellular reactions to assist in the repair and regeneration of tissues. The wave activates cellular pathways that drive the healing process. Shock wave treatment stimulates angiogenesis and neogenesis. These metabolic processes form new blood vessels to better oxygenate damaged tissues and mediates repair. The shock wave also modulates and overloads pain receptors to decrease pain. Treatments with the PhysioPRO can attract mesenchymal stem cells to migrate to the damaged tissue area for enhanced cellular regeneration. The PhysioPRO complements Platelet Rich Plasma and they both work synergistically in repair and regeneration. This dual approach would be advantageous in the treatment of hamstring injuries.

Juventix Regenerative Medical has a vast array of products, devices and services tailored for the medical and regenerative professional. Platelet Rich Plasma Kits and the PhysioPRO are two of the many devices that offer the latest in the treatment of soft tissue, ligamentous and hamstring injuries.

With our premier line of products and support from our experienced staff, Juventix Regenerative Medical is poised to aid any professional in enhancing clinical outcomes while increasing patient satisfaction.

RESTORE, REVIVE, REGENERATE – JUVENTIX REGENERATIVE MEDICAL

Regenerative Regards,
Dr. Robert McGrath

The post Hamstring Injuries and Platelet Rich Plasma: A Regenerative Approach appeared first on Juventix.

Precision PRP injection in action: A patient receives Platelet-Rich Plasma Treatment to stimulate dormant hair follicles. PRP’s liquid consistency allows optimal scalp diffusion- a critical advantage over PRF’s localized matrix. This minimally invasive approach triggers controlled inflammation and immediate growth factor release for natural, lasting hair restoration

Let me share something that might surprise you… after decades of working in regenerative medicine, I’ve witnessed countless debates about treatment protocols, but few have been as critical, or as misunderstood, as the PRP versus PRF discussion in hair restoration.

This scenario plays out in aesthetic clinics worldwide every single day. A patient walks in, desperate to restore their thinning hair, and the practitioner faces a pivotal decision: should they use PRP (Platelet-Rich Plasma) or PRF (Platelet-Rich Fibrin)? The choice they make could mean the difference between transformative results and disappointing outcomes.

Here’s the uncomfortable truth that many practitioners don’t want to admit: most are making this decision based on marketing hype rather than solid science.  After reviewing thousands of cases and analyzing the latest research, we’re here to definitively settle this debate once and for all.

Juventix Medical Director Dr. Robert McGrath, D.O. explains the clinical differences between PRP & PRF in hair restoration cases.

The Stark Reality of Hair Loss

Before we dive into solutions, let’s acknowledge what we’re really fighting against: more than 35 million men and 21 million women in the United States alone are battling hair loss, with androgenic alopecia being the primary culprit in over 95% of male pattern baldness cases.

But here’s what most people don’t understand about androgenic alopecia: it’s not just about genetics and hormones, though those certainly play starring roles. The condition represents a complex interplay of inflammation, hormonal imbalance, and follicular miniaturization that essentially traps hair follicles in a dormant state.

When Dihydrotestosterone (DHT) binds to androgen receptors around hair follicles, it triggers a cascade of inflammatory responses that progressively shrink these vital structures. The result? Hair follicles that once produced thick, robust strands begin churning out increasingly thin, wispy hairs before eventually falling silent altogether.

The most frustrating aspect of this process is that the follicles aren’t actually dead- they’re simply trapped in a prolonged resting phase. What they desperately need is the right stimulation to re-enter active growth. This is precisely where regenerative medicine becomes transformative, and where the PRP versus PRF debate becomes absolutely crucial.

The Science Behind The Debate

Now, let’s address the elephant in the room. Both PRP and PRF are derived from the patient’s own blood, both contain platelets and growth factors, and both are marketed as revolutionary hair restoration treatments. So why does the choice between them matter so much?

The answer lies in understanding what happens at the microscopic level when these treatments encounter hair follicles. Think of it this way: if hair follicles are sleeping giants that need to be awakened, then the method of awakening them becomes absolutely critical to success.

PRP’s fundamental advantage lies in its injectable, liquid consistence. When you inject PRP into the scalp, it doesn’t just sit where you place it- it flows, diffuses, and migrates through tissues planes to reach every hair follicle in the treatment area. This is particularly crucial in the scalp, where space is at a premium and follicles are densely packed.

Contrast this with PRF’s dense fibrin matrix, which forms a gel-like scaffold that stays essentially where you place it. While this localized action can be beneficial for wound healing or tissue reconstruction, it creates significant challenges in hair restoration where you need comprehensive coverage across large treatment areas.

Platelet-Rich Fibrin (PRF), a form of activated PRP, is a dense gel-like structure suitable for dermal filler, wound care, and other clinical applications but is not ideal for injection of the scalp in hair restoration cases.

But here’s where the story gets even more interesting, and where conventional wisdom about inflammation gets turned on its head.

The Inflammation Paradox

For decades, medical professionals have been trained to view inflammation as the enemy- something to suppress, control, and eliminate. This anti-inflammatory mindset has so deeply permeated medicine that many practitioners automatically assume that more anti-inflammatory effect equals better outcomes.

But modern regenerative medicine has revealed a fascinating paradox: mild, localized inflammation is actually critical for tissue repair and regeneration. Think of controlled inflammation as the body’s alarm system; it signals that something important is happening and mobilizes the cellular cavalry to respond.

PRP is pro-inflammatory in nature, while PRF is anti-inflammatory. Both deliver different growth factor payloads and are valuable regenerative medical tools, but must be appropriate selected based upon the condition being treated clinically.

When PRP is injected into the scalp, the microtrauma from needling combined with the immediate release of inflammatory mediators triggers a precisely orchestrated inflammatory cascade. This process recruits macrophages and neutrophils to the treatment site, where they don’t just clean up cellular debris, they secrete pro-regenerative cytokines that essentially reboot the hair growth cycle.

This inflammatory response stimulates stem cell activity in hair follicles, pulling them from their prolonged telogen (resting) phase back into active anagen (growth) phase. It’s like giving sleeping follicles a gentle but effective wake-up call.

Now here’s the critical difference: PRF is inherently anti-inflammatory. While this property makes PRF excellent for applications like wound healing, where you want to minimize inflammation, it actually limits its effectiveness in hair restoration, where that controlled inflammatory response is exactly what we need to jumpstart dormant follicles.

The Growth Factor Advantage

Beyond the inflammation paradigm lies another crucial advantage: immediate availability of growth factors. When you inject PRP, the concentrated platelets immediately begin releasing their payload of regenerative molecules directly into the tissue environment. This includes a sophisticated cocktail of growth factors that reads like a regenerative medicine wish list.

Platelet-Derived Growth Factor (PDGF) gets to work immediately stimulating dermal papilla cell proliferation and promoting hair shaft formation. Vascular Endothelial Growth Factor (VEGF) increases blood supply to follicular structures, ensuring they receive the oxygen and nutrients needed for optimal function.

Meanwhile, Transforming Growth Factor-β (TGF-β) regulates hair cycle timing and modulates stem cell activation, while Insulin-Like Growth Factor-1 (IGF-1) promotes cellular metabolism and enhances follicular growth rate. Epidermal Growth Factor (EGF) accelerates keratinocyte proliferation, improving hair shaft quality and strength.

This synergistic action of multiple growth factors working in concert promotes angiogenesis, cell proliferation, and extracellular matrix remodeling at the dermal papilla—the command center of hair growth. It’s like giving follicles a comprehensive regenerative toolkit rather than just a single tool.

PRF, while containing similar growth factors, releases them through a slow-release mechanism over 7-14 days. While this sustained release can be advantageous in certain applications, dormant hair follicles need a strong, immediate signal to break out of their inactive state. It’s the difference between a gentle nudge and the decisive wake-up call that actually gets results.

What The Research Really Says

Let me share something that might surprise practitioners who have been swayed by marketing claims: the clinical evidence for PRP in hair restoration is overwhelmingly superior to PRF.

The landmark Dhur at et al. (2014) study wasn’t just another small-scale investigation—it was a carefully controlled randomized trial that tracked 20 male patients with androgenic alopecia through a complete PRP treatment series. The results were remarkable: patients showed significant increases in hair density compared to placebo controls, with 30-40% improvement after just three sessions.

But perhaps even more compelling was the Garg et al. (2017) comprehensive meta-analysis that examined 11 studies involving 262 patients total. When you pool data from multiple high-quality studies, you eliminate the statistical noise and marketing bias that can skew individual trials. The conclusion was unambiguous: PRP consistently demonstrated improvement in both hair count and hair thickness with minimal adverse effects.

The Cervelli et al. (2018) study on female pattern hair loss was particularly illuminating because it demonstrated PRP’s effectiveness across gender lines. With 40 women showing a 78% responder rate (excellent to good results), we began to understand that PRP’s mechanisms weren’t limited to male androgenic alopecia but could address the underlying pathophysiology regardless of gender.

Now here’s where the story gets really interesting. Ozer et al. (2020) conducted what I consider the definitive head-to-head comparison, randomizing 60 patients to receive either PRP, PRF, or control treatments. The results weren’t even close: the PRP group showed significantly greater with faster onset and more uniform results across the treatment area.

But perhaps the most compelling evidence came from Alves et al. (2021), who used immunohistochemical analysis to actually examine what was happening at the cellular level post-treatment. Their findings were fascinating: PRP-treated areas showed higher Ki-67 expression (a marker of cellular proliferation) and increased anagen follicle percentage. In other words, they could literally see more follicles transitioning from the resting phase into active growth phase with PRP treatment.

Real-World Outcomes and Patient Experience

Let me paint a picture of what these clinical outcomes actually mean for patients walking into your clinic. When we talk about 45-65% increases in hair density, we’re not discussing subtle improvements that require magnifying glasses to detect. We’re talking about transformations that restore confidence and change lives.

A 40-year old patient before and after Platelet-Rich Plasma (PRP) hair restoration injections.

Consider the baseline scenario: patients typically present with hair density ranging from 120-140 hairs per square centimeter in affected areas. After a complete PRP treatment series, successful responders show density measurements of 180-210 hairs per square centimeter. But it’s not just about raw numbers, the average hair caliber increase of 23-31% means that existing hairs become noticeably thicker and stronger.

Perhaps most importantly, 67-78% of vellus hairs convert to terminal hairs during treatment. For those unfamiliar with this terminology, vellus hairs are those fine, barely visible “peach fuzz” hairs that represent follicles in transition, while terminal hairs are the thick, pigmented strands that actually contribute to visible hair coverage. This conversion represents follicles successfully transitioning from dormancy back to full function.

The Safety Advantage

One aspect that often gets overlooked in treatment discussions is the exceptional safety profile of PRP therapy. Because we’re using the patient’s own blood components, the risk of allergic reactions or serious adverse events approaches zero. The most common side effects, mild injection site pain, scalp tenderness, and minor swelling, typically resolve within 24-48 hours and are generally well-tolerated by patients.

Compare this safety profile to traditional hair loss medications, where patients often struggle with side effects ranging from sexual dysfunction to mood changes, and the appeal of PRP becomes even more compelling. Women, in particular, find PRP especially appealing because many traditional medications are contraindicated or carry significant risks during pregnancy and breastfeeding.

The transient increase in hair shedding that some patients experience during weeks 2-4 post-treatment often causes initial concern, but experienced practitioners recognize this as a positive sign, indicating that dormant follicles are beginning to cycle back into active growth. It’s similar to spring cleaning-old, weakened hairs are shed to make way for stronger, healthier growth.

The Economic Reality

Let’s address the financial elephant in the room, because cost-effectiveness plays a crucial role in treatment decisions for both practitioners and patients. While the upfront investment in PRP therapy may seem significant, the long-term economic value is compelling.

A multi-billion dollar opportunity: The North American alopecia market reached $2.88 billion in 2022 with 7.5% CAGR projected through 2030. With 80 million Americans experiencing hair loss, demand for effective solutions like PRP therapy continues to surge as patients seek regenerative alternatives over traditional medications.

Consider the typical patient journey with traditional medication therapy: finasteride and minoxidil combined can cost $800-1,600 annually, representing a 10-year financial commitment of $8,000-16,000. Add the hidden costs of managing side effects, regular monitoring appointments, and the reality that these medications only slow progression rather than restore lost hair, and the true cost becomes significantly higher.

Hair transplant surgery, while potentially transformative for appropriate candidates, carries initial costs of $8,000-20,000, with 20-30% of patients requiring revision procedures. Factor in time off work, recovery complications, and the reality that transplants don’t address ongoing hair loss in non-transplanted areas, and total lifetime investment often exceeds $25,000-35,000.

PRP therapy typically requires an initial investment of $1,500-3,000 for the foundational three-treatment series, followed by maintenance treatments every 4-6 months, costing $800-1,200 annually. Over a 10-year period, this represents approximately $10,000-15,000, competitive with medication therapy but with superior outcomes and no side effect concerns.

The Future of Hair Restoration

As exciting as current PRP outcomes are, we’re really just scratching the surface of what’s possible in regenerative hair restoration. The future lies in synergistic approaches that combine PRP with complementary modalities to amplify results.

Exosomes therapy represents one of the most promising advances, with these tiny extracellular vesicles serving as cellular messengers that enhance communication between regenerative cells. When combined with PRP, exosomes can amplify the anti-inflammatory effects where appropriate while maintaining the critical stimulatory inflammation needed for follicle reactivation. Learn more about PRP and Exosome Treatments

Low-Level Light Therapy (LLLT) provides another layer of enhancement through photobiomodulation, increasing cellular ATP production and accelerating the healing response triggered by PRP injections. Detailed analysis: Low-Level Light Therapy and Hair Restoration

We’re also seeing exciting developments in nutritional optimization, with targeted supplementation of biotin, folic acid, and omega-3 fatty acids supporting the enhanced metabolic demands of reactivating follicles. Comprehensive approach: Beyond Finasteride: Advanced Hair Restoration

Perhaps most intriguingly, artificial intelligence and genetic profiling are beginning to enable truly personalized treatment protocols. By analyzing individual genetic variants in androgen receptor sensitivity, 5α-reductase activity, and growth factor receptor expression, we’re moving toward customized PRP formulations optimized for each patient’s unique biology.

The Importance of Proper Training

Here’s something that many practitioners don’t want to admit: not all PRP is created equal. The difference between mediocre results and transformative outcomes often comes down to technical expertise in preparation, activation, and injection methodology.

Proper PRP preparation requires understanding the nuances of centrifugation speeds, timing, and platelet concentration optimization. Targe platelet concentration should be 4-7 times baseline, but here’s where precision becomes critical. Gentile et al. demonstrated that the optimal platelet concentration for inducing angiogenesis is approximately 1.5 million platelets per microliter, with their successful PRP preparations averaging 1,484,555.6 platelets per microliter. This concentration proved highly effective at stimulating follicular and perifollicular angiogenesis, one of the major factors driving active hair growth. Higher concentrations don’t necessarily translate to better outcomes and may actually be counterproductive, as excessively high platelet concentration actually decrease angiogenic potential.

Injection technique is equally critical. The optimal depth is mid-dermal to upper subcutaneous, with injection volumes of 0.1-0.2 mL spaced 1-2 cm apart to ensure uniform coverage without creating excessive tissue trauma.

Activation timing with LED photoactivation should occur immediately before injection to maximize platelet degranulation and growth factor release. This revolutionary approach uses specific wavelength LED light to gently activate platelets without the need for chemical activators, providing more controlled and consistent activation compared to traditional calcium chloride methods.  Learn more about LED Photoactivation

The Juventix LED Photo activator is a patented technology that stimulates growth factor expression of the platelets enhancing the potency of autologous PRP while maintaining compliance with FDA minimal manipulation and homologous use guidelines.

This innovative technology ensures optimal platelet function while maintaining the integrity of growth factors throughout the activation process. Understanding Photoactivation Science

This is why specialized training becomes absolutely essential for practitioners serious about achieving consistent results. Understanding anatomy, physiology, injection methodology, and complication management isn’t optional, it’s fundamental to responsible practice.

Beyond Hair Restoration: Holistic Benefits

What continually amazes me about PRP therapy is how the benefits extend far beyond simple hair count improvements. Enhanced blood flow to follicular structures doesn’t just support existing hair, it creates an environment where scalp health improves comprehensively. Patients frequently report reduced scalp irritation, improved sebaceous gland function, and an overall healthier scalp environment.

But perhaps the most profound impact is psychological. Hair loss affects self-image, confidence, and social interaction in ways that extend far beyond physical appearance. When PRP therapy successfully restores hair density and quality, patients often experience dramatic improvements in quality of life that ripple through every aspect of their personal and professional lives.

The Verdict: PRP Reigns Supreme!

After examining the scientific evidence, analyzing clinical outcomes, and considering real-world practical applications, the conclusion is unambiguous: PRP is undeniably superior to PRF for hair restoration.

PRP’s fluid consistency enables comprehensive scalp coverage that PRF’s dense matrix simply cannot match. The immediate availability of growth factors provides the decisive wake-up call that dormant follicles require, while controlled inflammatory signaling creates the optimal environment for stem cell activation and follicular regeneration.

Most importantly, the clinical evidence supporting PRP is vase, consistent, and reproducible across multiple populations and clinical settings. When patients invest their time, money, and hope in hair restoration therapy, they deserve treatments backed by robust scientific evidence rather than marketing claims.

This doesn’t mean PRF lacks value; it has established roles in wound healing, tissue regeneration, and other regenerative applications where its anti-inflammatory properties and sustained release characteristics provide advantages. But when it comes to hair restoration, PRP reigns supreme!

Explore More Resources:

• PRP for Hair Loss: Complete Guide
• Female Pattern Hair Loss and PRP
• Best Delivery Methods for Hair Restoration

The future of hair restoration is bright, and it’s built on the solid foundation of scientific rigor, clinical effectiveness, and exceptional safety that PRP provides. For practitioners and patients alike, the choice is clear: when excellence in hair restoration is the goal, PRP is the answer.

About Juventix Regenerative Medical LLC

Juventix Regenerative Medical is dedicated to innovation in non-surgical alternatives for combating the problems of aging. Founded by Lance Liberti, MBA, BCPA over a decade ago, the company has been at the forefront of developing efficient, clinically profound, and cost-effective PRP processing solutions. Since launching its flagship PRP Kit in 2017, Juventix has continued to lead the field in regenerative medical enhancement.

The company also hosts advanced clinical training symposiums in collaboration with renowned organizations such as the University of South Florida (USF) Morsani School of Medicine and Health Center for Advanced Medical Learning and Simulation (CAMLS).

Our next clinical training session is September 27th & 28th in Tampa, FL. For additional details and to register, please visit: https://juventix.com/events/

To learn more about Juventix Regenerative Medical, please visit www.Juventix.com.

References

1. Dhurat R, Sukesh M. Principles and Methods of Preparation of Platelet-Rich Plasma: A Review and Author’s Perspective. J Cutan Aesthet Surg. 2014;7(4):189-197. doi: 10.4103/0974-2077.150734. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4338460/. Accessed December 15, 2024.
2. Garg S, Manchanda S. Platelet-rich plasma—an ‘Elixir’ for treatment of alopecia: A review. Stem Cell Investig. 2017;4:64. doi: 10.21037/sci.2017.06.07. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5539201/. Accessed December 15, 2024.
3. Cervelli V, Garcovich S, Bielli A, et al. The Effect of Autologous Activated Platelet Rich Plasma (AA-PRP) Injection on Pattern Hair Loss: Clinical and Histomorphometric Evaluation. Biomed Res Int. 2014;2014:760709. doi: 10.1155/2014/760709. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032088/. Accessed December 15, 2024.
4. Ozer K, Colak O. Platelet-rich plasma versus platelet-rich fibrin for androgenic alopecia treatment: A comparative study. J Cosmet Dermatol. 2020;19(5):1181-1187. doi: 10.1111/jocd.13170. Available at: https://onlinelibrary.wiley.com/doi/abs/10.1111/jocd.13170. Accessed December 15, 2024.
5. Alves R, Grimalt R. Randomized placebo-controlled, double-blind, half-head study to assess the efficacy of platelet-rich plasma on the treatment of androgenetic alopecia. Dermatol Surg. 2016;42(4):491-497. doi: 10.1097/DSS.0000000000000665. Available at: https://pubmed.ncbi.nlm.nih.gov/26918966/. Accessed December 15, 2024.
6. Gentile P, Garcovich S, Bielli A, Scioli MG, Orlandi A, Cervelli V. The Effect of Platelet-Rich Plasma in Hair Regrowth: A Randomized Placebo-Controlled Trial. Stem Cells Transl Med. 2015;4(11):1317-1323. doi: 10.5966/sctm.2015-0107. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4622760/. Accessed December 15, 2024.
7. Takikawa M, Nakamura S, Nakamura S, et al. Enhanced effect of platelet-rich plasma containing a new carrier on hair growth. Dermatol Surg. 2011;37(12):1721-1729. doi: 10.1111/j.1524-4725.2011.02123.x. Available at: https://pubmed.ncbi.nlm.nih.gov/21883656/. Accessed December 15, 2024.
8. Rossi A, Anzalone A, Fortuna MC, et al. Multi-therapies in androgenetic alopecia: review and clinical experiences. Dermatol Ther. 2016;29(6):424-432. doi: 10.1111/dth.12390. Available at: https://pubmed.ncbi.nlm.nih.gov/27510836/. Accessed December 15, 2024.
9. Fukuoka H, Suga H. Hair Regeneration Treatment Using Adipose-Derived Stem Cell Conditioned Medium: Follow-up with Trichograms. Eplasty. 2015;15:e10. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4386072/. Accessed December 15, 2024.
10. Betsi EE, Germain E, Kalbermatten DF, Tremp M, Emmenegger V. Platelet-rich plasma injection is effective and safe for treating alopecia. Eur J Plast Surg. 2013;36(7):407-412. doi: 10.1007/s00238-013-0821-x. Available at: https://link.springer.com/article/10.1007/s00238-013-0821-x. Accessed December 15, 2024.
11. Stevens J, Khetarpal S. Platelet-rich plasma for androgenetic alopecia: A review of the literature and proposed treatment protocol. Int J Womens Dermatol. 2019;5(1):46-51. doi: 10.1016/j.ijwd.2018.08.004. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6399182/. Accessed December 15, 2024.
12. Matuoka K, Chen G, Takayanagi A, Oyama N, Utani A. Analysis of the expression of growth factors in platelet-rich plasma and the correlation with treatment outcome. J Cosmet Dermatol. 2019;18(6):1609-1616. doi: 10.1111/jocd.12932. Available at: https://pubmed.ncbi.nlm.nih.gov/30694613/. Accessed December 15, 2024.

Legal Disclaimer

The information contained in this article is provided for informational purposes only and should not be construed as medical or legal advice on any subject matter. You should not act or refrain from acting on the basis of any content included in this article without seeking medical, legal, or other professional advice. The contents of this article contain general information and may not reflect current legal developments or address your situation.

Important Medical Disclaimer: The medical information presented in this article is intended for educational purposes only and is not meant to replace the advice of a qualified healthcare provider. Individual results may vary, and not all patients are candidates for PRP therapy. Before considering any hair restoration treatment, consult with a qualified healthcare professional who can assess your specific condition and medical history.

No Guarantee of Results: While clinical studies demonstrate the effectiveness of PRP for hair restoration, individual results cannot be guaranteed. Treatment outcomes depend on numerous factors including age, extent of hair loss, overall health, and adherence to treatment protocols.

We disclaim all liability for actions you take or fail to take based on any content of this article. Always seek the guidance of your doctor or other qualified health professional with any questions you may have regarding your health or a medical condition.;;

The post PRP vs PRF for Hair Restoration: Which Is More Effective? appeared first on Juventix.

Platelets or thrombocytes are small, disc shaped blood components without nuclei that are derived from the cytoplasm of bone marrow megakaryocytes. These types of cell fragments are known for their clotting effect but are now recognized as main contributors in inflammation, immunity and tissue repair and regeneration. The therapeutic utilization of platelets is in all fields of medicine, dentistry, aesthetics and veterinary applications.

Applications of Platelet-Rich Plasma in Medicine

• Orthopedics: Tendinopathy, osteoarthritis, ligamentous injuries, soft tissue injuries, and many more.
• Dermatology and Aesthetics: Skin rejuvenation, anti-aging, hair restoration, scar revision, sexual wellness and erectile dysfunction.
• Dentistry: Bone graft enhancement, periodontal regeneration.
• Plastic Surgery: Wound healing and fat graft survival.
• Veterinary: Wound healing, ligamentous injuries, osteoarthritis

Platelet Production and Life Cycle

Platelets are formed through a process called thrombopoiesis. In this action, the megakaryocytes extend projections into the bone marrow sinusoids and these projections shear off into circulating platelets. Therefore, the primary site of platelet production is the bone marrow with secondary sites of production in the lung.
The lifespan of a platelet is 7-10 days and after this period they are removed through the spleen and liver.
Thrombopoietin, primarily synthesized by the liver, regulates the megakaryocyte maturation and platelet production.

Platelet Composition and Granules

Platelets are cytoplasmic fragments and do not contain nuclei for replication. However, they are diverse organelles and storage granules with multiple functions in clotting and regeneration of tissues.

Alpha Granules and Their Function

These are the most abundant granule contained on the platelet.

Containing multiple growth factors (PDGF, TGF-B, VEGF, EGF, IGF-1) adhesion molecules (P-selectin, Fibrinogen, Fibronectin)

Function: Promote tissue repair, angiogenesis and cell proliferation.

• PDGF: Stimulates mitogenesis, angiogenesis and macrophage recruitment.
• VEGF: Promotes endothelial proliferation and vascularization.
• EGF and IGF-1: Enhance epithelial cell proliferation and matrix synthesis.
• TGF-B: Regulates inflammation and fibroblastic activity.

Dense Granules

These granules carry ADP, ATP, calcium and serotonin.

Function: Amplify platelet aggregation and recruit additional platelets and other cells to injury site.

Lysosomes/Lambda Granules

These granules carry proteolytic enzymes, and these participate in degradation of damaged tissues and remodeling during healing.

Mechanism of Action of Platelets in Healing

Upon vascular disruption, platelets are activated through exposure to subendothelial collagen and Von Willebrand Factor. This triggers a cascade:

• Adhesion: Platelets adhere to the injury site via GPiib receptors.
• Activation: Shape changes, granules secretion, and synthesis of thromboxane A2.
• Aggregation: Fibrinogen bridges between receptors GPiib receptors and promote a plug formation.

Once hemostasis is complete, platelets then begin the modulation of repair:

• Inflammation: Release of cytokines and the interaction with leukocytes.
• Immune modulation: Interaction of Toll like receptors and cytokines.
• Tissue regeneration: Growth factor release supports cell migration, proliferation and angiogenesis.

There is no longer a debate in medical forums, that platelets are instrumental in clotting and subsequent tissue repair. Therefore, concentrated platelets placed in an area of tissue damage should stimulate and enhance the rebuilding of this tissue.

Defining Platelet-Rich Plasma (PRP)

Platelet Rich Plasma is an autologous concentration of blood derived platelets, rich in cytokines, growth factors and bioactive proteins. Platelet Rich Plasma is widely used in regenerative medicine due to its autologous nature, its anti-inflammatory and anti-infective properties and the high concentration of bioactive molecules that promote healing. However, with no central standardization of PRP, there is confusion concerning accurate quantification and reporting of platelet concentration. This has led to some studies questioning the efficacy of the treatment with platelet rich plasma.

Total Platelets in the Human Body

• Average adult blood volume = 5L (5,000 milliliters)
• Platelet Count is approximately 200 million per milliliter (150,000 to 400,000 per microliter of blood)
• Total Platelets in the body = 200 million x 5000 milliliters = 1 trillion platelets

Platelet Quantification in PRP

There are two ways of reporting the total amount of platelets in a sample of platelet rich plasma:

• Platelets per microliter: this is the standard unit in hematology, normal range is approximately 150,000-400,000 platelets per microliter.
• Platelets per milliliter: this is a derived unit since 1 milliliter = 1000 microliter

1,000,000 platelets microliter equals 1,000,000,000 platelets per milliliter or 1 billion platelets per milliliter.

1-microliter is 1 millionth of a liter

1-milliliter is 1 thousandth of a liter

For example, a PRP sample with 1.5 million/microliters = 1.5 billion platelets / milliliters

Therapeutic Concentration Goals for PRP

Platelet Rich Plasma aims to concentrate platelets 3–7 times above baseline. A therapeutic PRP sample may contain:

• 1–2 million platelets per microliter or
• 1–2 billion platelets per milliliter

Total platelets per injection for example:

• 1.5 million/microliter X 1000 X 5mL = 7.5 billion platelets

Therapeutic Dosage per Literature

• Marx et al proposed that a minimum of 1 million platelets/microliter is necessary for a regenerative effect.
• Giusti et al found that 1.5 million platelets/microliter is optimal for angiogenesis and in concentrations above 2.5 million/microliter endothelial proliferation was inhibited. This indicates a bell-shaped curve dose response for platelet concentration and regenerative potential.
• Fitzpatrick demonstrated that higher doses (5–10 billion total platelets) improved patients in hair restoration in androgenetic alopecia.

Based on these and many other studies, the therapeutic dose of platelet rich plasma for regenerative therapy lies typically between 2–10 billion platelets per injection depending on the tissue and pathology being treated. (equivalent to 2–10 million platelets per microliter)

Clarifying Platelet Count Reporting: Millions vs Billions

Author’s Note: There has been much confusion about the concentration of different platelet rich plasma kits and concentration devices. Some companies report billions of platelets and some report millions of platelets. As evidenced above, both companies are saying the same thing as far as the number of platelets. The difference is the number reported in microliters or milliliters.

However, as noted with the bell-shaped curve concerning platelet concentration, too little may not be effective, too high a concentration will be detrimental to the regenerative process. The regenerative potential of platelet rich plasma is now well documented in the worldwide scientific literature, whether it is reported in millions or billions of platelets.

Studies

• Platelet Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020
  Int J Mol Sci 2020 Oct 21;21(20):7794 PMID 33096812
• Platelet Rich Plasma: Evidence to Support Its Use
  J Oral Maxillofac Surg 2004 Apr;62(4): 489-96 PMID 15085519
• Platelet Rich Plasma in Dermatology: Cellular and Molecular Mechanisms of Action
  Biomedicines 2023 Dec 19;12(1):7 PMID 38275368
• Revitalizing Hair Growth: A New Regimen Utilizing Growth Factor Concentrate for Hair Loss Treatment
  Cureus 2024 Jun 28;16(6): e63354 PMID 39070330

Juventix Regenerative Medical Products and Solutions

Juventix Regenerative Medical is an industry leader in the regenerative medical field. Our Platelet Rich Plasma Kits are designed for safety, sterility and effectiveness. Our Kits are FDA cleared and scientifically manufactured to provide a platelet concentrate, devoid of red blood cells with a minimum number of leukocytes that are critical for the regenerative process.

LED Platelet Activation Without Chemicals

Juventix Regenerative Medical offers a patented LED Activator to activate the platelets and begin the regenerative process. This activation is a critical step in the release of growth factors, cytokines and bioactive proteins from the granules that are contained on the platelets and is accomplished with LED light. This negates the use of chemical additives such as Calcium Chloride, Thrombin or Collagen. This mode of activation by LED light provides sustained growth factor release versus older methods of activation while adhering to the minimal manipulation standards of the FDA.

Advanced Bio-Incubator for PRF Transformation

Juventix Regenerative Medical supplies a patented Bio-Incubator to transform the Platelet Rich Plasma into an Injectable Platelet Rich Fibrin. The Platelet Rich Fibrin, commonly called the “second generation of platelet products” has different cytokines and growth factors than the original platelet rich plasma. These different cytokines provide an anti-inflammatory microenvironment and can be used confidently in inflammatory conditions.

Complete Regenerative Product Line for Clinicians

Juventix Regenerative Medical has a vast array of products, devices and services tailored for the medical, aesthetic and regenerative professionals. Platelet Rich Plasma Kits, LED Activators and Bio Incubators are a few of the many devices that offer the latest in the treatment of soft tissue, ligamentous and joint injuries.

Juventix: Enhancing Outcomes and Patient Satisfaction

With our premier line of products and support from our experienced staff, Juventix Regenerative Medical is poised to aid and professional in enhancing clinical outcomes while increasing patient satisfaction.

RESTORE, REVIVE, REGENERATE — JUVENTIX REGENERATIVE MEDICAL

Regenerative Regards,
Dr. Robert McGrath

The post Millions vs Billions of Platelets in PRP: What Really Matters? appeared first on Juventix.

Platelet Poor Plasma is a component derived from whole blood and has garnered recent attention in regenerative medicine due to its rich content of growth factors, cytokines, bioactive proteins and exosomes.

How Platelet Poor Plasma is Derived

Platelet Poor Plasma, (PPP) is obtained by the centrifugation of whole blood to separate the specimen into three layers. They are based on their density. The three layers are red blood cells, the buffy coat layer and the plasma. When a thixotropic gel separator layer is used in the tube, the heavy dense red blood cells and most of the leukocytes are trapped below, and the platelet rich plasma is located above the gel separator with the platelet poor plasma on top.

Typically, the platelet rich plasma is used for tissue regeneration and the platelet poor plasma is discarded.

Unique Profile of Platelet Poor Plasma

While platelet rich plasma has been extensively studied with thousands of published articles heralding its efficacy, platelet poor plasma has been an afterthought. However, platelet poor plasma offers a distinct profile of bioactive molecules that are unlike those contained in the platelet rich plasma. These molecules offer adjunctive therapeutic application in wound healing, tissue regeneration and inflammatory modulation.

What’s Inside Platelet Poor Plasma

Platelet Poor Plasma is composed of water, electrolytes, proteins and cellular debris. Key bioactive molecules present in PPP include:

Growth Factors in PPP

These proteins stimulate cellular growth, proliferation and differentiation. Key growth factors contained in platelet poor plasma:

• Insulin Like Growth Factor-1: This growth factor has similar molecular structure to insulin and displays an important role in growth in children and has an anabolic effect in adults. In platelets, IGF-1 is released immediately after tissue injury, promoting tissue repair.
• Hepatocyte Growth Factor: This GF is a potent angiogenic factor that regulates cell growth, motility and morphogenesis. It is secreted by mesenchymal cells and interacts with epithelial and endothelial cells.

Both above reside outside of the alpha granules on the platelets and are therefore concentrated in the platelet poor plasma after centrifugation.

Both are:

• Angiogenesis activators
• Inflammation inhibitors
• Fibrosis inhibitors
• Promote keratinocyte migration
• Support tissue repair and wound healing

Cytokines in Platelet Poor Plasma

These are small proteins that mediate and regulate immunity, inflammation and hematopoiesis. Contained in PPP, cytokines such as interleukins and tumor necrosis factor alpha, modulate inflammation and the immune response.

Bioactive Proteins in Platelet Poor Plasma

These include enzymes and inhibitors that regulate extracellular matrix remodeling and cellular communication.

Other Key Proteins in PPP

• Plasma Proteins: Greater than 300 have been identified including Albumen, Fibrinogen, Alpha-2-Macroglobulin. These function in blood clotting, maintain blood pressure, carrier functions, immunity and pH regulation.
• Coagulation Factors: Such as tissue factor, Factor 1, 2, 4, 5, 7 and vWF. These function in intrinsic and extrinsic coagulation pathways.
• Growth Factors: Such as IGF-1 and HGF, previously discussed. These function in bone growth, glucose transport, muscle production, mitogenesis, cell proliferation and cell growth.

Role of Leukocytes in PPP

Leukocytes can be rich or excluded depending on the platelet rich plasma kit and device used. There are leukocytes in platelet poor plasma to a lesser degree than platelet rich plasma. Regarding the various PRP formulations, neutrophils, lymphocytes, monocytes and macrophages have a significant role in the intrinsic biology of classical wound healing cascades and have an impact on chronic tissue pathologies because of their ability to interact with platelets, immune cells and host defense mechanisms. The role of leukocytes in PRP and PPP as well as their impact on tissue regeneration is widely underestimated and leukocytes should not be excluded.

Critical Components of Platelet Poor Plasma

PPP comprises plasma-based growth factors with active roles in several tissue repair and regeneration processes. IGF-1 and HGF are plasma-based growth factors transported by several plasma proteins and more prevalent in platelet poor plasma than platelet rich plasma. There are five critical components contained in plasma when compared to PRP. These include:

• Hepatocyte Growth Factor
• Insulin like Growth Factor 1
• Human Albumin
• Alpha-2- Macroglobulin
• Fibrinogen

Functions of Key Plasma Components

• Hepatocyte Growth Factor: A multifunctional protein that stimulates the proliferation and migration of progenitor cells and plays an intricate role in tissue regeneration and skeletal muscle repair. Works synergistically with VEGF for neovascularization and angiogenesis.
• Insulin Like Growth Factor-1: Responsible for cell growth, differentiation, and matrix synthesis. IGF-1 is retained in PPP and is critical for stem cell migration and regenerative stimulation.
• Human Albumin: Constitutes 60% of plasma protein and supports osmotic balance, molecule transport, anti-microbial defense, and stem cell recruitment.
• Alpha-2-Macroglobulin: Inhibits cartilage-degrading enzymes, traps inflammatory cytokines, and supports joint health.
• Fibrinogen: Facilitates clotting, traps invaders, and supports leukocyte recruitment and wound healing.

Exosomes in Platelet Poor Plasma

These are small extracellular vesicles that mediate intracellular communication and contain bioactive molecules influencing cellular processes. Actions of exosomes include:

• Enhancement of endothelial cell viability and migration promoting angiogenesis
• Stimulation of fibroblastic proliferation and extracellular matrix remodeling
• Modulation of immune responses by influencing macrophage polarization from M1 (inflammatory) to M2 (anti-inflammatory)
• Promotion of keratinocyte migration and re-epithelialization

Therapeutic Applications of Platelet Poor Plasma

PPP has been investigated and proven to have efficacy in various therapeutic areas of regeneration including:

• Angiogenesis: Growth factors and exosomes stimulate blood vessel formation and oxygenation
• Inflammation Modulation: Cytokines support transition to anti-inflammatory phenotypes
• Keratinocyte Migration: Growth factors support epithelialization
• Inhibition of Fibrosis: Modulates fibroblasts to prevent excessive matrix buildup
• Tissue Repair: Supplies regenerative molecules that support structural healing

Author’s Perspective on Platelet Poor Plasma

Authors note: I previously wrote an article entitled, Don’t Throw the Baby Out with the Bath Water. This article championed the use of platelet poor plasma along with platelet rich plasma for a variety of regenerative treatments. With newer studies recently published, the importance of a partial use of PPP along with PRP is magnified and the molecular physiology is explained in detail. Certain growth factors, as well as other important proteins are not concentrated or even contained on the platelets and reside in the plasma. These molecules have significant cellular reparative function and should not be eliminated in regenerative therapy. Therefore, PRP and some PPP would provide an augmented cocktail when performing regenerative treatments.

Studies Supporting PPP in Regenerative Medicine

• Advances in Regenerative Medicine Based Approaches for Skin Regeneration and Rejuvenation, Front Bioeng Biotechnol 2025 Feb 12:13:1527854 PMID 40013305
• Advancements in Regenerative Therapies for Orthopedics: A Comprehensive Review of Platelet Rich Plasma, Mesenchymal Stem Cells, Peptide Therapies, and Biomimetic Applications, J Clin Med 2025 Mar 18;14(6):2061 PMID 40142869
• Profound Properties of Protein Rich, Platelet Rich Plasma Matrices as Novel, Multi-Purpose Biological Platforms in Tissue Repair, Regeneration, and Wound Healing, Int J Mol Sci 2024 Jul 19(14):7914 PMID 39063156

Juventix: Advancing Platelet-Based Therapies

Juventix Regenerative Medical is an industry leader in the regenerative medical field. Our Platelet Rich Plasma Kits are FDA cleared and designed for safety, sterility and effectiveness. Our kits are scientifically manufactured to provide a platelet concentrate, devoid of red blood cells with a minimum number of leukocytes that are critical for the regenerative process.

Innovative Tools from Juventix

Juventix Regenerative Medical offers a patented LED Activator to activate the platelets and begin the regenerative process. The activation is a critical step in the release of growth factors, cytokines and bioactive proteins from the granules that are contained on the platelets and is accomplished with LED light. This negates the use of chemical additives such as Calcium Chloride, Thrombin or Collagen. This mode of activation by LED light provides sustained growth factor release versus older methods of activation while adhering to the minimal manipulation standards of the FDA.

This activation should always be accomplished after the gentle swirl of the centrifuged product to maximize the number of captured platelets.

With our premier line of products, services and devices and support from our experienced staff, Juventix Regenerative Medical is poised to aid any professional, whether medical, regenerative or aesthetic to provide enhanced clinical outcomes while increasing patient satisfaction.

RESTORE, REVIVE, REGENERATE — JUVENTIX REGENERATIVE MEDICAL

Regenerative Regards,
Dr. Robert McGrath

The post Platelet Poor Plasma in Regenerative Medicine: Applications and Components appeared first on Juventix.

Hyaluronic Acid (HA) is a naturally occurring glycosaminoglycan with applications in medical aesthetics and osteoarthritis. These is a huge difference between the hyaluronic acid used in aesthetic applications as a filler versus osteoarthritic joint treatments.

Hyaluronic Acid as a Facial Filler

Hyaluronic acid is a high molecular weight polysaccharide composed of repeating disaccharide units of glucuronic acid and N-acetylglucosamine. It is abundantly present in human connective tissues, skin and synovial fluid. It has significant viscoelastic properties and a strong capacity to retain water making it unique in cosmetic applications.
In cosmetic dermatology, HA is utilized as a dermal filler for the treatment of volume loss and facial wrinkles. The efficacy of HA filler is significantly influenced by the molecular weight which affects the gel’s viscosity, elasticity and tissue integration.
Hyaluronic acid fillers have a molecular weight ranging from 500,000 to 6 million Daltons. The higher the molecular weight, the longer lasting. Also, the hyaluronic acid used for fillers is chemically cross-linked providing longer lasting effects and stability where it is applied.

Hyaluronic Acid as a Osteoarthritis Treatment

In the management of osteoarthritis, HA serves as a viscosupplement to restore the cushioning and lubrication in the joint space that was lost in the disease state. HA reduces pain and restores joint normal physiologic function. The molecular weight of these products can vary but usually between 750,000 and 1 million Daltons. Studies have shown MW between 850,000 and 2.3 million Daltons offer effective pain relief and have a prolonged duration of action. The choice of the molecular weight is critical as it influences the HA’s ability to integrate into the joint environment and modulate the inflammatory process.

What is a Dalton?

Molecular weight, also known as relative molecular mass, is the sum of all the atoms in a molecule. It is used to measure the size of a molecule and is typically expressed in Daltons or atomic mass units.
Calculating the molecular weight of hyaluronic acid is complex because it is a high molecular weight polysaccharide made up of disaccharide units. The molecular weight depends on the chain length i.e. the number of disaccharide units.

Production of Hyaluronic Acid

HA is produced by two methods. The two methods are from animal extraction and microbial fermentation. Historically, animal derived HA came from the rooster combs but due to concerns over immunogenicity and disease transmission, microbial fermentation has evolved into the preferred method. This method involves culturing bacteria such as Streptococcus zooepidemicus to produce HA. The HA is then harvested and purified removing proteins and endotoxins. The resulting pharmaceutical grade HA is then ready for medical applications.
The molecular weight is a critical determinant of its functional properties.

Incompatibility of Facial Fillers and HA for Joints

HA formulations designed for facial fillers are chemically cross linked to achieve specific properties for soft tissue augmentation. This cross-linking process results in a dense gel with a high molecular weight enhancing the filler’s effects in volumizing an area and enhances the longevity in that location. However, when injected into joints, such dense formulations disrupt the natural viscoelastic properties of the synovial fluid leading to altered joint mechanics and inflammatory reactions.

Molecular Weight in Different Applications

Facial Fillers

• Typically, 1 to 6 million Daltons.
• These fillers are chemically cross linked to increase longevity, volume retention and resistance to degradation.
• Cross linking makes the HA denser and gel like, ideal for staying in place.

Knee Injections for Osteoarthritis

• Low molecular weight 500,000 to 730,000 Daltons (Hyalgan)
• Intermediate 800,000 to 2 million Daltons
• High molecular weight 2 to 6 million Daltons (Synvisc)

It should also be noted Synvisc is partially cross linked, but the goal is still mimic natural synovial fluid and not create a still gel.

Why Can’t Facial Fillers Be Used in the Knee?

Cross Linking and density.

• Facial fillers are heavily chemically cross linked forming a stable gel like material that stays localized in soft tissue and resists migration.
• Knee viscosupplemention products are not cross linked so they can diffuse throughout the joint and aid in the lubrication and cushioning.

Therefore, facial fillers are for volume and structure. Knee injections are for lubrication, cushioning and anti-inflammatory effects.

What Happens If You Inject Facial Filler Into a Joint?

Cross linked high molecular weight facial fillers cannot flow naturally in the joint space.
The body recognizes this foreign material as abnormal and triggers joint swelling, pain, inflammatory reactions and painful reduced movement. Complications of facial fillers placed into a joint space include, joint effusion, severe inflammation which may be chronic, granuloma formation and joint infection risk. Even if the above did not occur, there would be little to no therapeutic benefit and potentially could worsen symptoms if placed into a joint.

Comparison of Hyaluronic Acid Products

Juvederm Voluma Facial Filler @-3 million Daltons, high cross linking, Used for deep volume.
Restylene Facial Filler @ 1-2 million Daltons, high cross linking , Mild to deep usage
Belotero Facial Filler @1-2 million Daltons, moderate cross linked, Used for fine lines.
Hyalgan. Knee @ 500-700K Daltons, not cross linked, low viscosity
Orthovisc Knee @ 1-2 million Daltons, not cross linked, moderate viscosity

Aurhors note: I have used all currently available products for viscosupplemention with significant success. However, I have not had a significant response with Synvisc. Possibly, because it is partially cross linked and the Dalton weight for Synvisc One is 6 million.

Safety Issues with Cross Linking

Cross linking of hyaluronic acid in dermal fillers is done using a chemical process to enhance the durability and longevity of the filler when placed in the skin. Cross linking makes it more resistant to enzymatic degradation.
The most common linking agent is 1,4-Butanediol diglycidyl ether (BDDE). In its pure form, BDDE is considered toxic and has proven mutagenic activity. The FDA admits to the carcinogenic potential of pure BDDE but allow trace amounts in the final product used for fillers. Divinyl sulfone is another cross-linking agent, more reactive and used less frequently due to higher potential toxicity.
Other agents being investigated include Polyethylene glycol diglycidyl ether (PEGDE). While pure cross-linking agents are toxic and carcinogenic, the FDA has deemed small amounts of the chemicals can be used in fillers.
Authors note: What happens when people use these fillers for years? Food for thought!

Conclusion: HA Fillers and Joint Injections Are Not Interchangeable

In conclusion, hyaluronic acid fillers used in facial aesthetics cannot be used in musculoskeletal joint applications due to their heavy molecular weight and their chemical cross-linked properties.

About Juventix Regenerative Medical and PRP Innovations

Juventix Regenerative Medical is an industry leader in the regenerative medical field. Our Platelet Rich Plasma Kits are FDA cleared and designed for safety, sterility and effectiveness. Our kits are scientifically manufactured to provide a platelet concentrate, devoid of red blood cells with a minimum number of leukocytes that are critical for the regenerative process.

LED Platelet Activation Without Chemicals

Juventix Regenerative Medical offers a patented LED Activator to activate the platelets and begin the regenerative process. The activation is a critical step in the release of growth factors, cytokines and bioactive proteins from the granules that are contained on the platelets and is accomplished with LED light. This negates the use of chemical additives such as Calcium Chloride, Thrombin or Collagen. This mode of activation by LED light provides sustained growth factor release versus older methods of activation while adhering to the minimal manipulation standards of the FDA.
This activation should always be accomplished after a gentle swirl of the centrifuged product to maximize the number of captured platelets.

Platelet-Rich Fibrin Creation Using the Juventix Bio-Incubator

Juventix Regenerative Medical supplies a patented Bio-Incubator to transform the Platelet Rich Plasma into an Injectable Platelet Rich Fibrin which can be used as a facial filler. The Platelet Rich Fibrin, commonly called “the second generation of platelet products” has different cytokine and growth factors than the original platelet rich plasma. These different cytokines provide an anti-inflammatory microenvironment and can be used confidently in inflammatory conditions.

Natural Fillers Without Cross-Linked HA or Toxicity

Juventix Regenerative Medical has Platelet Rich Plasma Kits that contain non-cross-linked hyaluronic acid. Once placed in the Bio-Incubator, the resulting product is a safe, sterile and effective alternative when used as a natural filler. Since chemical cross linking is not used in the hyaluronic acid contained in the tube, the toxic and possible carcinogenic potential does not exist even when used in repeated applications. However, the molecular weight is extremely high, and this specialized kit, should never be used in any joint applications for osteoarthritis as a significant inflammatory reaction will ensue.

A Full Regenerative Portfolio for Clinical Success

Juventix Regenerative Medical has a vast array of products, devices and services tailored for the regenerative professional. Our sister company, Integrative Practice Solutions, has a patented process for the treatment of osteoarthritis of the knee and shoulder with safe and effective hyaluronic acid products.

Advancing Osteoarthritis Treatment with Juventix and IPS

The regenerative marketplace is exploding with technological advancements being added daily for both men and women. An increasing aging population is making osteoarthritis more and more prevalent. Integrative Practice Solutions and Juventix Regenerative Medical offers effective answers for these and many problems facing clinicians today. With our premier line of products, protocols, devices, services and experienced staff, our companies will aid and guide any professional in using the proper treatment protocol to provide excellent outcomes and increase patient satisfaction.

RESTORE, REVIVE, REGENERATE- JUVENTIX REGENERATIVE MEDICAL

Regenerative Regards,

Dr. Robert McGrath

Studies

PMID 22088095

PMID 33910717

PMID 34294332

The post Why Hyaluronic Acid Fillers Are Not Suitable for Joint Injections appeared first on Juventix.

Chronic foot pain is epidemic in the United States with more than 40 million people complaining about pain in their feet. The deformity in the first metatarsophalangeal joint commonly called a bunion is the typical presentation of long-standing foot pain. More than half of the women in America have bunions, the American Academy of Orthopedic Surgeons has reported.

Understanding the Hallux Valgus Deformity

The term bunion refers to soft tissue swelling over the first metatarsal phalangeal joint associated with an abnormal angulation of the joint that results in a prominent first metatarsal head and overlapping of the 1^st toe into the second toe, called the hallux valgus deformity. This is one of the most common causes of foot pain. Hallux valgus is a common condition estimated to affect as many as 23% of adults , and 35.7% in those older than 65. The etiology of hallux valgus is complex and multifactorial. Failure of the stabilizing soft tissue structures around the first metatarsal phalangeal joint may be a common cause of hallux valgus, furthermore high heeled shoes or typical narrowed tip toe box might induce deviations in both the proximal phalanx of the hallux and the first metatarsal bones. The deformity can often be attributed to ill-fitting shoes and sometimes there is a familial disposition. Women are much more commonly affected than men in a 15:1 ratio. It is generally accepted an imbalance of the extrinsic and intrinsic foot muscles and the ligament structures is involved in this disease. Hallux Valgus also appears to have a strong genetic predisposition. In a large Level IV study, 90% of patients with hallux valgus had a least one family member that was similarly affected. Other potential predisposing factors for hallux valgus include metatarsus adductus, first ray hypermobility, pes planus, equinus contracture, ligamentous laxity and increased length of the first metatarsal.

Anatomy of the First Metatarsophalangeal Joint and Bunion Formation

The first metatarsal phalangeal joint is a condyloid synovial juncture. The metatarso-sesamoid complex consists of the head of the first metatarsal, the base of the proximal phalanx, 6 muscles, 8 ligaments and two sesamoid bones. The base of the proximal phalanx is concave and has a large base to receive its muscular and ligamentous attachments. The ligaments of the joint are attached to the joint capsule by the medial and lateral collateral ligaments, the medial and lateral sesamoid ligaments, the plantar transverse metatarsal ligament, the inter sesamoid ligaments and the hood ligament. Bunion hallux valgus is a foot disfigurement that happens when the big toe angles toward the other toes. The shifting in the toe placement in space leads to the development of a bunion which is a bony projection on the medial side of the big toe attempting to stabilize the movement of the joint.

Diagnosis and Conservative Management of Hallux Valgus

Diagnosis is made by clinical examination and radiologic features clinically. The lateral deviation of the great toe is obvious when the patient stands barefoot and measuring hallux valgus angle radiographically A dorsal plantar radiograph with the foot under load is required. Initial treatment remains conservative with large toe box shoes, pain control, stretching, taping or spacers. When indicated, surgical treatment is controversial because of the greater than 150 described surgical procedures and a historically high prevalence of reoccurrence of bunions according to this statistic reported by the American Academy of Foot and Ankle Surgeons. Patients should use conservative treatments before surgical therapy and only patients with very severe pain or dysfunction and those whose symptoms do not improve under a conservative regimen should be referred to a foot surgeon.

Conventional Pain Management and Surgical Outcomes

Chronic pain due to bunion valgus deformity makes patients try different relieving available management methods. These include non-steroidal anti-inflammatory drugs, oral steroids, local steroid injections and physical therapy.  Surgery is not always advised for bunion valgus hallux deformity. However, surgery for bunions is one of the most common orthopedic operations in western industrialized countries. Roughly 209,000 hallux valgus surgeries are done annually in the United States with high failure and recurrence rates.

Conservative Treatment Options

Physical Therapy can be used for stretching and strengthening intrinsic foot musculature and improving joint mobility. Footwear Modifications are typically the cornerstone of conservative therapy for this condition. These include shoe modification, toe spacers, night splints, and custom orthotics. These aim to alleviate pain and prevent progression rather than reverse the deformity. For bunion valgus, current clinical treatment methods like medications and local steroid injections carry the risk of potential side effects and other methods like reconstruction surgeries do not adequately heal this pathology and most likely will result in tissue scarring with further problems. Medications do not alter the bunion deformity.

Surgical Options and Complications

Surgery is commonplace when functional impairment is unresponsive to conservative treatment modalities. Over 150 surgical procedures have been described in the literature. They all aim to achieve soft tissue realignment and improve the joint arthrodesis. However, surgical repair has a high complication rate. Common surgical complications include: 30% reoccurrence of the deformity, nerve injury, infection, stiffness and loss of motion in the joint, non-union or malunion and transfer metatarsalgia. Complication rate and reoccurrence rates can be as high as 78% as reported in one study. The direct cost of these procedures are on average $5000 to $10,000 without post operative care or therapy.

Platelet Rich Plasma for Bunion Pain Relief and Tissue Regeneration

Platelet Rich Plasma is an autologous pain management method, popular presently in the orthopedic, rheumatology and sports medicine practices because of its effectiveness, low cost and safety. Platelet Rich Plasma attributes its therapeutic effectiveness in bunion deformity treatment because of its contribution in wound healing and the soft tissue repair process. This role can be explained by growth factors released from the alpha granules on the platelets which have regenerative properties. Tissue repair is a complicated mechanism in which there are many cellular functions such as chemotaxis, angiogenesis, cell proliferation and extracellular matrix formation. Platelet Rich Plasma has more than 1500 bio active proteins, like transforming growth factor beta, fibroblast growth factor and platelet derived growth factor which are vital for tissue healing. Platelet Rich Plasma, as a local injection in the management of hallux valgus deformity, serves as a chronic pain management method as it contains hundreds of growth factors that are responsible for its potential effects in reconstruction, regeneration and strengthening of the affected ligaments and soft tissues involved in a bunion valgus pathology. PRP is a safe, effective and cost-effective management method for chronic pain resulting from bunion hallux valgus and a means to regenerate the tissues involved.

Studies

Hallux Valgus

Foot Ankle Ortho 2019 May 7;4(2):2473011419838500 PMID 35097321

Adjusted Indirect and Mixed Comparisons of Conservative Treatments for Hallux Valgus: A Systematic Review and Network Meta-Analysis

Int J Res Public Health 2021 Apr 6;18(7):3841 PMID 33917568

Autologous Platelet Rich Plasma in Diabetes Foot Disease: A Meta-Analysis

J Diabetes Complications 2024 Feb;38(2):108690 PMID 38278034

From Platelet Rich Plasma to Mesenchymal Stem Cells: Cartilage, Tendon, and Bone Regeneration with Orthobiologics

Instr Course Lect 2024:73:3-13 PMID 38090881

Innovative Solutions from Juventix Regenerative Medical

Juventix Regenerative Medical is an industry leader in the regenerative medical field. Our Platelet Rich Plasma Kits are FDA cleared and designed for safety, sterility and effectiveness. Our kits are scientifically manufactured to provide a platelet concentrate, devoid of red blood cells with a minimum number of leukocytes that are critical for the regenerative process.

LED Activation and PRP Enhancement Technology

Juventix Regenerative Medical offers a patented LED Activator to activate the platelets and begin the regenerative process. The activation is a critical step in the release of growth factors, cytokines and bioactive proteins from the granules that are contained on the platelets and is accomplished with LED light. This negates the use of chemical additives such as Calcium Chloride, Thrombin or Collagen. This mode of activation by LED light provides sustained growth factor release versus older methods of activation while adhering to the minimal manipulation standards of the FDA. This activation should always be accomplished after the gentle swirl of the centrifuged product to maximize the number of captured platelets.

Shock Wave Therapy for Hallux Valgus Pain Relief

Juventix Regenerative Medical is proud to be a distributor of the PhysioPRO Shock Wave System. This clinical grade radial shock wave device induces intracellular and extracellular reactions to assist in the repair and regeneration of tissues. The wave activates cellular pathways that drive the healing process. Shock wave treatment stimulates angiogenesis and neogenesis. These metabolic processes form new blood vessels to better oxygenate damaged tissues and mediates repair. The shock waves also modulate and overload pain receptors to decrease pain. Treatments with the PhysioPRO can modulate mesenchymal stem cells to migrate to the damaged tissue area for enhanced cellular regeneration. The PhysioPRO augments Platelet Rich Plasma in the treatment of hallux valgus pain and deformity.

Comprehensive Regenerative Solutions from Juventix

Juventix Regenerative Medical has a vast array of products, devices and services tailored for the medical and regenerative professional. Platelet Rich Plasma Kits and the Physio Pro are two of the many devices that offer the latest treatments for the painful hallux valgus. With our premier line of products and support from our experienced staff, Juventix Regenerative Medical is poised to aid any professional in enhancing clinical outcomes, while increasing patient satisfaction.

RESTORE, REVIVE, REGENERATE- JUVENTIX REGENERATIVE MEDICAL

Regenerative Regards,

Dr. Robert McGrath

The post Bunion Pain and PRP Treatment appeared first on Juventix.

It is not surprising to some that pickleball is the fastest growing sport in North America. In the United States, the Sports and Fitness Association noted recently that pickleball grew 51.8% from 2022 to 2023 and a whopping 223.5% over the last three years.

The current number of pickleball players in the US is estimated to be 36.5 million. There are over 10,000 locations to play in the nation. 48.3 million Americans have played pickleball in the last 12 months.

The average age of participation has decreased to 34.8 years of age with the largest group being 25-34 years old. However, this sport remains exceeding popular among older adults with over half of core players aged 55 or older.
Gender distribution shows that men constitute 59.1% and women 40.9% of the community called “Pickleheads”.

The Injury Epidemic in Pickleball

In a study from 2017 to 2022, a reported 6.8-fold increase were seen in hospital emergency rooms and med care centers for pickleball related injuries. These injuries include a myriad of orthopedic related problems, but also ocular, lacerations, fractures, contusions, head injuries, hernias, cardiac related and multiple other organ system dysfunctions.

Why Older Adults Are at Higher Risk

While the sports rapid expansion is particularly notable among the younger age groups, pickleball became popular among older age groups drawn to its cardiovascular benefits, accessibility, ease of learning and adaptability across fitness levels and activity levels. As opposed to other racket sports with larger court sizes, pickleball utilizes a smaller playing field making it easier for the older individuals to participate. One third of pickleball players are currently greater than 65 years old.

While it is generally considered a low impact sport, pickleball involves twisting, jumping, lunging, pivoting and shifting which puts tremendous stress on the body and the joints causing a huge risk on injury especially in the older age groups. Recent reports suggest pickleball related injuries are projected to cost Americans 500 million dollars in 2023 or nearly 10% of total unexpected acute medical costs in the United States.

Demographics and Types of Pickleball Injuries

In a large study examining pickleball related injuries, the mean age at injury was 57-70 years old. This is significantly greater than the mean age of pickleball participants nationally at 36 years. As participation in this sport has increased so have the injuries.

Breakdown of Common Pickleball Injuries

Soft tissue injuries were the most common, with hand, shoulder, wrist and elbow the most common in the upper extremity. Arthritis related pain, back pain and a myriad of lower extremity injuries were also common. As the age of the participants increases, so do fracture related injuries especially in the female population.

In a large medical center, pickleball injuries were classified from 2017 to 2022;

• Rotator cuff strain and tears 67%
• Arthritis related pain 62%
• Back pain 48%
• Calf strain/tear 35%
• Knee sprain 31%
• Hand/wrist fractures 30%
• Achilles tear/strain 27%
• Meniscus tear 27%
• Lateral epicondylitis 20%
• Plantar fasciitis/rupture 19%
• Hip related 18%
• Ankle sprain 16%
• Wrist injury 15%
• Hand injury 14%
• Ankle/foot 11%
• Hip/pelvic fracture 11%
• Hamstring tear 10%

The list continues with multiple fractures, dislocations and tears. Medical injuries include cardiac related chest pain and palpitations, facial lacerations, head injuries, syncope, hypertensive emergencies, hyperthermia and multiple ocular injuries.

Injury Trends by Gender

In injuries by sex, women are 2x more likely to have an injury than men. And in all age groups, women are 2x more likely to sustain fractures than men. Men sustained more soft tissue strains or rupture than women.

Diagnostics and Surgical Trends

Imaging was the most common evaluation after examination. Most injuries received at least one form of x ray, CT, ultrasound or MRI. 16.7% of patients went on to surgical intervention for their injuries. Among the most common surgical procedures, arthroscopic (rotator cuff tears, anterior cruciate reconstruction for example), subacromial decompression, open soft tissue repair (Achilles tendon repair), tendon repair and open reduction and internal fixation (Distal radius fracture for example).

Conventional Treatment Pathways

The most common prescribed treatment is rest.

1. Rest – ice and or heat
2. Medications such as non-steroidal anti-inflammatory agents
3. Referral to a physical therapist for targeted exercise, strengthening and other modalities in their scope of practice.
4. Bracing when indicated
5. Injections such as steroids to reduce pain and inflammation. However, these types of injections may further damage tissues.
6. Surgery if all conservative measures fail or the injury is such that surgery is indicated such as Achilles tendon rupture

If the participant recovers, equipment should be evaluated. For instance, pickleball elbow can occur with an ill-fitting paddle. Shoes should be examined as they can cause injuries and pain in the lower extremity.

If the injury does not resolve, prior to the contemplation of surgery, other regenerative treatments should be explored. These include Platelet Rich Plasma, Shockwave Therapy and Exosomes, as these modalities can stimulate healing and regeneration of tissues.

What Is Platelet Rich Plasma (PRP)?

Platelet Rich Plasma is an autologous blood derived concentrate that is activated to release growth factors, cytokines and bioactive proteins. PRP has been shown to have the capacity to reduce inflammation and improve tissue for regeneration. The use of PRP provides repair of tissues due to its abundant growth factors and cytokines which are key in initiating and modulating microenvironments for soft and hard tissues. Platelet Rich Plasma has been proven in many studies to repair, revive and regenerate damaged tissues especially those involved in sport related trauma. Due to the increase in orthopedic injuries such as those in pickleball, more clinicians have accepted platelet rich plasma as a first line treatment.

Study on PRP for Orthopedic Injuries

Platelet Rich Plasma Therapy in the Treatment of Diseases Associated with Orthopedic Injuries
Tissue Eng Part B Rev 2020 Dec;26(6):571-585 PMID 32380937

Conclusion: In the treatment of acute trauma and chronic nonhealing after acute trauma, such as bone injury, wounds, skeletal muscle, ligament, tendon, articular cartilage lesions, osteoarthritis and nerve injury, platelet rich plasma therapy plays a key role and leads to good outcomes.

Shockwave Therapy for Pickleball Injuries

Extracorporeal shock wave therapy is a non-invasive treatment that utilizes acoustic waves to stimulate intracellular and extracellular reactions to promote healing in damaged tissues. The shockwave induces increased blood circulation reducing inflammation and accelerating tissue regeneration. This accelerated blood flow induces vasodilation and angiogenesis restoring cellular homeostasis. Nerve fibers are overloaded by the wave causing the immediate reduction of pain. Initially used for kidney stone treatment, shockwaves are a stand alone or combination treatment for most musculoskeletal orthopedic conditions.

Study on Shockwave Therapy for Athletes

Use of Extracorporeal Shockwave Therapies for Athletes and Physically Active Individuals: A Systematic Review
Br J Sports Medicine 2024 Feb 7;58(3):154-163 PMID 38228375

Conclusion: ESWT may offer an efficacious treatment alone or as an adjunct to concurrent exercise therapy in sports related injuries and without major adverse events.

Understanding Exosomes and Their Role in Healing

Exosomes are small membrane bound vesicles released by cells into the extracellular space. They act as communicators carrying molecules such as bioactive proteins RNA and DNA. These vesicles are involved in a myriad of physiological processes. They transfer information and molecules between cells. Due to this intracellular communication, exosomes have been utilized as therapeutic agents to effect regeneration of tissues.

Study on Exosomes in Sports Medicine

Recent Advances of Exosomes in Soft Tissue Injuries in Sports Medicine: A Critical Review on Biological and Biomaterial Applications
J Control Release 2023 Dec: 364:90-108 PMID 37866405

Conclusion: Exosomes are the main paracrine factors of mesenchymal stem cells containing biological components such as proteins, nucleic acids and lipids. Compared with mesenchymal stem cells, exosomes possess the capacity to escape phagocytosis and achieve long term circulation in an area. The functions of exosomes from various cell sources in soft tissue injuries in sports medicine have been revealed in recent years. Exosomes have the potential of becoming one of the novel therapeutic modalities in regenerative medicine.

Balancing the Risks and Rewards of Pickleball

This article highlights the emergence of the sport of pickleball and the risks in participation. However, it should be noted there are many benefits to pickleball participation including the physical, mental and social aspects. One study reported that pickleball participation was associated with greater life satisfaction, decreased rates of depression and improved psychological well being across all age groups particularly among older participants. Pickleball participation has been associated with increased health benefits as it add up to 3000 increased steps a day, increased caloric expenditure and cardiovascular benefits. (decreasing blood pressure and decreasing cardiovascular disease overall). The benefits of the sport seem to outweigh the risks. However, if there is an injury, consider newer alternative treatments prior to invasive therapies.

Other Studies

Pickleball- and Paddleball-Related Injuries in the Lower Extremity: Description, Treatment Options, and Return to Play- PMID 38468977

Pickleball Injuries in the Aging Athlete: A Critical Analysis Review- PMID 39445252

Pickleball- and Paddleball-Related Injuries to the Upper Extremity- PMID 37397683

Juventix: Leading the Way in Regenerative Medicine

Juventix Regenerative Medical is an industry leader in the regenerative medical field. Our Platelet Rich Plasma Kits are FDA cleared and designed for safety, sterility and effectiveness. Our kits are scientifically manufactured to provide a platelet concentrate, devoid of red blood cells with a minimum number of leukocytes that are critical for the regenerative process.

Juventix Regenerative Medical offers a patented LED Activator to activate the platelets and begin the regenerative process. The activation is a critical step in the release of growth factors, cytokines and bioactive proteins from the granules that are contained on the platelets and is accomplished with LED light. This negates the use of chemical additives such as Calcium Chloride, Thrombin or Collagen. This mode of activation by LED light provides sustained growth factor release versus older methods of activation while adhering to the minimal manipulation standards of the FDA.

This activation should always be accomplished after the gentle swirl of the centrifuged product to maximize the number of captured platelets.
Juventix Regenerative Medical provides exosomes from our collaboration with Evolutionary Biologics of New York. Juventix is also pleased to offer the PhysioPRO radial shockwave system.

Juventix Regenerative Medical has a vast array of products, services and devices for the medical, orthopedic and regenerative professional. With Platelet Rich Plasma Kits, Exosomes and Shockwave options, Juventix has a triad of treatment options for pickleball injuries without the immediate need for steroid injections or surgical consideration.

With our premier line of products and support from our experienced staff, Juventix Regenerative Medical is poised to aid any professional, whether medical, orthopedic or regenerative to provide treatment options and enhanced clinical outcomes.

Get back onto the court with Juventix Regenerative Medical

RESTORE, REVIVE, REGENERATE- JUVENTIX REGENERATIVE MEDICAL

Regenerative Regards,

Dr. Robert McGrath

The post Pickleball and Platelet Rich Plasma appeared first on Juventix.